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T cells play important roles in adaptive immunity through mediating clearance of 
bacteria, virus, and cancer cells. T cell receptor (TCR) recognizes antigen presented on the 
surface of antigen presenting cells (APC) in the form of peptide major histocompatibility 
complex (pMHC). Based on this information, T cells must make fate decisions, such as 
expansion or differentiation, that are critical to proper T-cell function. TCR does not 
contain signaling capability by itself. Instead, intracellular signaling is initiated from the 
signaling motif found on the cytoplasmic tails of neighboring CD3 subunits. Therefore, 
understanding how TCR and its neighboring CD3 subunits function as a unit is important 
for deciphering T cell activation and designing therapeutics aimed at shaping T-cell 
responses. Recently, more evidence has indicated that force is required in TCR-pMHC 
interaction and T cell activation, and kinetics of interaction under force show different 
behavior from force-free conditions. Leveraging findings from these recent studies, strong 
emphasis was placed on investigating the role of force in TCR triggering and signaling in 
this thesis. 
In this thesis, two-dimensional (2D) kinetics of TCR interaction with CD3 on the 
extracellular domain was characterized in the present and absence of force, and the impact 
of mutations affecting TCR-CD3 interaction have on TCR antigen recognition was 
investigated. Based on these findings, TCR-CD3 interaction in the extracellular domain 
was identified to play a unique role of relaying force from the pMHC recognition end to 
the intracellar signaling end of the TCR complex.  
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In the second part of the thesis, the scope was extended to coreceptor CD8 and the 
role of force in formation of TCR-pMHC-CD8 trimolecular interaction was investigated in 
the context of thymocyte selection. Force was found to provide a unique readout in 
functional outcome of thymocytes through differentiating positive selecting ligands from 
negative selecting ligands. By further probing factors affecting the formation of this 
trimolecular interaction, the Lck-dependency in CD8 contribution to the trimolecular 
interaction was identified, which revealed an inside-out arm of TCR signaling to 
complement and influence the well-known outside-in path mediated by TCR recognition 
of pMHC. 
Overall, these findings provide a deeper understanding of TCR triggering and early 
signaling from the perspective of TCR-CD3 interaction and outside-in/inside-out loop of 
signal integration with the common theme of mechanical force as significant factor 






CHAPTER 1. INTRODUCTION 
T cell mediated immune response in adaptive immunity is an essential part of our 
defense system against bacterial and viral infections, toxins, and cancer cells. T cells 
generate a huge repertoire of TCRs through the rearrangement of V,D, and J gene 
fragments. TCRs have remarkable sensitivity as they can be triggered by as few as a single 
agonist pMHC. At the same time, TCRs are highly specific in the sense that they recognize 
specific foreign pMHCs in the presence of a large excess of self-pMHCs. In addition, small 
differences in the sequence of presented peptide may lead to large differences in functional 
outcome of T cells. Because the specific interaction between TCR and pMHC leads to T 
cell activation and cellular immune response, it has been the subject of extensive research 
aimed at figuring out how TCR triggering occurs and how is TCR-pMHC binding related 
to T cell signaling events. At the current state, our understanding on the mechanism of TCR 
triggering and its relationship to T cell signaling is still incomplete, and it is the aim of this 
thesis to further our understanding on this topic and contribute to the collective effort to 
solve the puzzle that is TCR triggering. 
The objective of this thesis is to further our understanding on the role of force in T 
cell triggering and activation by investigating two different aspects of TCR triggering. 
First, emphasis was placed on probing the interaction between TCR and CD3 in the 
extracellular domain (Chapter 4), as it is the first point of communication between these 
two surface proteins and it initiates the transduction of pMHC recognition signal from TCR 
to intracellular signaling events occurring on the tails of CD3s. The focus of the first part 
is to characterize the interaction under force and force-free conditions, and relate the 
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kinetics of TCR-CD3 interaction to TCR antigen recognition, one of the most critical 
parameters in T cell mediated immune response.  
In the second part of the thesis, I switched gears to expand the scope beyond the TCR 
complex (i.e. TCR and its neighboring CD3 subunits) to include the contribution of 
coreceptor CD8 in antigen recognition and cell fate in the context of thymocyte selection 
(Chapter5). Thymocyte selection is the process where developing T cells interaction with 
APCs in thymic microenvironment to coordinate a selection of functional and self-tolerant 
T cell repertoire. As such, this process filter out those T cells that cannot signal strongly 
and those that are too reactive toward self-antigens, and the unsuccessful outcome of 
thymocyte selection often leads to autoimmune diseases where T cells attack healthy self-
tissues and cells through the recognition of self-peptides presenting on those cells. Building 
upon initial findings by Dr. Jinsung Hong, a past member of our lab, I found that CD8 
coreceptor, with its primary functions of stabilizing TCR-pMHC interaction and delivery 
of Lck to the TCR complex, contribute under force to produce a unique readout relevant to 
the outcome of thymocyte selection. By investigating potential factors influencing the 
contribution of CD8 to TCR-pMHC interactions, an inside-out arm of TCR signaling was 
identified in the sense that the outcome of intracellular activities has a direct impact on 
TCR recognition of pMHC, which is the start of the outside-in signaling arm of TCR 
signaling. 
Lastly, the thesis ends with my conclusions of current findings and recommended 
future directions to further what has been accomplished in this thesis and build our 
understanding toward solving the whole mechanism of TCR triggering (Chapter 6). A 
better understanding toward how T cells function is not only vital for explaining many 
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phenotypical symptoms we often see in T-cell mediated diseases, but also for developing 
better therapeutics to attenuate or strengthen T cell responses to fine tune immunity. In 
order to realize this end goal, there are many important questions that are still left to be 
addressed. 
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CHAPTER 2. BACKGROUND 
2.1 T Lymphocytes and TCR triggering 
 T lymphocytes play a central role in adaptive immune response against bacteria, 
viruses, toxins, and cancer cells through mediating direct killing of antigen-expressing cells 
(1). T cells recognize antigen in the form of pMHC presented on the surface of APCs to 
discriminate pathogens from self-antigens. Because of the important functions of T cells, 
understanding the unique specificity and sensitivity of TCR have been the subject of many 
studies, ranging from structural studies (2) to kinetics approaches (3, 4). Utilizing kinetics-
based assays, prior studies have found correlation between the affinity of TCR-pMHC 
interaction with T cell responsiveness (5). Despite much effort in the field to investigate 
how T cell ligation leads to T cell activation, the exact mechanism remains unclear. One 
of the key reasons for this lies in the unique structure of the TCR complex (Figure 1). The 
TCR complex is made of TCR with three surrounding CD3 subunits, namely CD3γε, 
CD3δε, and CD3ζζ (6, 7). TCR is responsible for interacting with pMHC, but it does not 
contain any signaling motif. Instead, intracellular signaling is initiated from the 
immunoreceptor tyrosine-based activation motif (ITAM) domains found on the 
cytoplasmic tails of CD3 subunits. Therefore, external triggering on TCR needs to be 
transmitted to its neighboring CD3 subunits. The transmembrane region of the TCR 
complex holds the different subunits together through attraction of opposite charges (8), 
and the presence of strong interaction has made this region a good candidate to study the 
communication between TCR and CD3s. However, although studies have shown that the 
transmembrane region could be responsible for transmitting a conformational change upon 
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TCR engagement (9), the earliest point of communication between TCR and CD3 remains 
at the extracellular domain. Despite that, specific interaction between the extracellular 
domains of TCR and CD3 has not been detected before using 3D kinetics measurements 
such as Surface Plasmon Resonance (SPR). The lack of measurement suggests that the 
interaction between TCR and CD3 in the extracellular domain is probably very week, if it 
exists. Another possible explanation for the absence of interaction can be attributed to the 
‘force-free’ environment that the measurements were taken in. Increasing evidence has 
point toward the existence of force contributed by actin polymerization, actin retrograde 
flow and myosin II-dependent contraction during TCR-pMHC ligation formed between 
cell interfaces (10) and subsequent formation of immunological synapse (11, 12). In 
relation to TCR triggering, a recent study has highlighted the importance of force in TCR-
pMHC interaction through demonstrating that force can prolong the lifetime of TCR-
pMHC interaction for agonistic peptides (13), which suggests a possible mechanism of 
TCR using interaction duration under force as a criterion to discriminate between agonist 
and antagonist peptides. Given that TCR interaction with agonistic pMHC can be enhanced 
with force, it is reasonable to hypothesize that the communication between TCR and CD3, 
a crucial step required to relay the pMHC recognition signal across the membrane, occurs 
in the presence of force as well. This novel approach to unraveling the relationship between 
TCR and CD3 will be explained in more details in Chapter 4.   
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Figure 1 - Structure of the TCR complex consists of an abTCR surrounded by three 
CD3 subunits, CD3ge, CD3de, and CD3zz held together through attraction of 
opposite charges in the transmembrane region. Adapted and modified from (8). 
Following TCR triggering by agonist pMHCs, the ITAMs on CD3 cytoplasmic tails 
will undergo phosphorylation by Lck (14). These phosphorylated ITAMs, in turn, provide 
docking sites for ZAP-70, another key kinase responsible for the propagation of early TCR 
signaling, which eventually leads to the opening of intracellular calcium channels to release 
Ca2+ from intracellular stores (15). This release of calcium flux is often used as a readout 
of early T cell activation (13, 16, 17). On the scale of hours, T cell activation can be 
characterized by expression of surface markers, and two such markers are CD69 and CD25. 
CD69 is one of the earliest surface antigens expressed by T cells after activation (18). Once 
expressed, CD69 acts as a costimulatory molecule for T cell proliferation. CD25 is the 
alpha chain of the Interleukin-2 (IL-2) receptor, and it is absence on naïve T cells. 
Following T cell activation, CD25 expression is upregulated.  
 7 
2.2 T cell receptor and CD3 
2.2.1 Extracellular interaction 
The extracellular interaction between TCR and CD3 influences the spatial 
organization of the TCR complex. Prior studies have used antibody-mapping (19), 
structural analysis (20, 21), mutagenesis studies (22) and charge complementarity studies 
to identify potential mocking sites of CD3 subunits (23) (Figure 2). One prominent model 
of TCR-CD3 extracellular organization places CD3 heterodimers on opposite sides of the 
TCR (24). In particular, this model proposed, based on evidences from solved solution 
structures of CD3 heterodimers, that CD3γε interacts with the constant region of TCRβ, 
which contains the FG loop. An earlier studies used H57, a monoclonal antibody (mAB) 
targeting the FG loop, to demonstrate that binding of H57 to the TCR reduces the 
subsequent staining using mAB 2C11, which binds to CD3ε, thus highlighting the 
importance of the FG loop in TCR-CD3 interaction (19). Apart from these, other possible 
docking sites have been proposed based on analyzing the crystal structure of TCR-pMHC 
complexes (25). Some of these proposed docking sites are overlapping, while the rest are 
far apart, as shown in Figure 2. More recent, studies have used nuclear magnetic resonance 
(NMR) spectroscopy to identify TCR-CD3 interaction sites (26) and small-angel X-ray 
scattering and electron microscopy (EM) to investigate the overall organization of the 
TCR-CD3 complex (21). Despite that, there has not been a consensus on the exact spatial 
organization of the TCR complex and one of the key reasons behind that is the lack of 
direct evidence of TCR-CD3 extracellular interaction. 
2.2.2 Signal initiation from CD3 intracellular tails  
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Apart from hosting the ITAMs, CD3ε cytoplasmic tails were found to show close 
interaction with the plasma membrane (27) using Fluorescence resonance energy transfer 
(FRET). This interaction involving basic residues on CD3ε and acidic phospholipids 
enriched in the inner leaflet of the plasma membrane embeds key tyrosines residues of 
ITAMs and sequesters their phosphorylation by Src kinases. A related study demonstrated 
that Ca2+ can regulate the charge property of lipids and bring about a dissociation of CD3 
cytoplasmic tails from the plasma membrane (28). This new function of Ca2+ is thought to 
amplify TCR signaling through increasing the availability of ITAMs, but this phenomenon 
has yet to address the question of how TCR recognition of pMHC can bring about the 
release of CD3ε cytoplasmic tails from the membrane, since Ca2+ flux is a downstream 
signaling event and is only capable of amplifying an existing signal. The cause of this 
intracellular conformational change as a consequence of TCR ligation is likely transmitted 
across the membrane by CD3 subunits.  Therefore, extensive research on the mechanism 
of CD3 cytoplasmic tail dissociation is warranted and should be focused not only on the 
intracellular conformational change alone but also its relationship to extracellular 
perturbation due to TCR ligation.  
 9 
 
Figure 2 – TCR complex subunits and proposed extracellular CD3δε and CD3γε 
interaction sites with αβTCR. Different color-coding represents proposed docking sites 
from different studies. Adapted from (25). 
2.3 Catch-bond and slip-bond 
If the duration of a bond is shortened by applied force, it is typically characterized as 
a slip-bond. In contrast, if the duration is prolonged by applied force, it is characterized as 
a catch-bond.  Even since the first experimental demonstration of catch-bond in the selectin 
system by our lab (29), many other surface receptors were found to exhibit catch-bond 
behavior till an optimal force level where the duration of the bond is the longest and further 
application of force shortens bond lifetime beyond that point (slip-bond phase). Examples 
of catch-bonds include TCR-pMH interaction (13), integrin a5b1 with fibronectin (30),  
aLb2 with intercellular adhesion molecule-1 (31), and platelet glycoprotein Iba interacting 
with von Willebrand factor (32). The collective profile of catch-then-slip bond will be 
referred to as catch-slip behavior in this thesis. 
2.4 Thymocyte development 
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Committed lymphoid progenitors from bone marrow migrate to thymus via blood. 
Once inside the thymus, these T-cell precursors have a double negative (DN; no CD4 or 
CD8) phenotype (33) (Figure 3). These DN thymocytes can be further subdivided into four 
group based on their surface expression of CD44 and CD25, such that DN1 is CD44+CD25-
, DN2 is CD44+CD25+, DN3 is CD44-CD25+, and DN4 is CD44-CD25- (34). For cells 
proceeding to express abTCR, they first express pre-Ta in association with a full TCRb 
chain at the DN3 stage (35). T cells that can actively signal proceed to express full TCRa 
chain, and subsequently, these thymocytes start to express CD8 and CD4 coreceptors and 
become double-positive (DP; CD4+CD8+) thymocytes (36). The DP stage marks the onset 
of TCR-mediated thymocyte selection. At this stage, most of the DP thymocytes express 
TCRs that interact poorly with the available self-pMHC found inside the thymus that they 
are unable to sustain the amount of intracellular signaling required for survive, which leads 
to death by neglect. The other subset of DP thymocytes that interact very strongly with 
self-pMHC will promote rapid apoptosis as a result of their signaling response in a process 
called negative selection, as its purpose is to eliminate those T cells with the potential to 
cause autoimmune diseases if allowed to leave the thymus. The remaining subset of DP 
thymocytes that can maintain survival signal but do not react too strongly to self-pMHC 
are chosen in the process called positive selection and they proceed along its developmental 
pathway to become lineage specific CD4+ or CD8+ single-positive (SP) T cells (37). 
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Figure 3 - Different stages of thymocyte development in the thymus. Committed 
lymphoid progenitor cells enter from blood and pass through DN stage to DP stage where 
both CD4 and CD8 coreceptors are expressed on cell surface. At the DP stage, thymocytes 
that do not signal are eliminated due to death by neglect. Thymocytes that interact with 
self-pMHC too strongly are induced to die by apoptosis. The remaining ones that signal 
strong enough to survive but not too strong to get negatively selected undergo positive 
selection and go on to lineage committed of either CD4+ or CD8+ SP thymocytes and 
prepare to migrate to periphery. Adapted and modified from (33). 
2.5 CD8 co-receptor 
Antigen recognition by the T cell is capable of discriminating peptides that differ by 
a single amino acid and trigger a wide range of T cell responses (38). TCRs bind to class I 
or II pMHCs with the help of CD8 or CD4 co-receptors, respectively. CD8 coreceptor 
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binds to a3 conservative domain of the MHC without making contact to the peptide. CD8-
MHC interaction is distinct from TCR binding to MHC, which only involves the a1 and 
a2 domains on the MHC (39, 40). The affinity of CD8-MHC interaction is much lower 
than that of TCR for agonist pMHC (41), suggesting that CD8 binding to MHC is primarily 
a helper function to stabilize TCR-pMHC bonds, especially for low affinity targets of the 
TCR (42). Intracellularly, CD8 associates with Src family kinase Lck (43), and it was found 
that CD8 associates with CD3 in the presence of Lck (44), and the absence of CD8 
prevented T Cell signaling by monomeric pMHC (45). Exactly how does pMHC bind TCR 
and CD8 has been a topic of much debate. Studies using soluble molecules in a fluid phase, 
i.e. 3D binding measurements using SPR, have generated conflicting results showing that 
CD8 and TCR bind pMHC independently (46), while another found that CD8 enhances 
TCR-pMHC interaction by reducing the off-rate (41). Utilizing 2D binding assays to better 
simulate pMHC interaction with TCR and/or CD8 across cell interface, a more recent study 
showed that CD8 binds cooperatively to TCR-pMHC interaction in a synergistic fashion 
to favor potent ligands by further enhancing binding and amplify discrimination of peptides 
(47). Building upon the findings from 2D kinetics studies and combined with the influence 
of mechanical force in amplifying TCR-pMHC interaction for agonist discrimination (13), 
I further investigated the contribution of TCR-pMHC-CD8 trimolecular interaction in the 
context of thymocyte selection and presented these findings in Chapter 5. 
2.6 DNA-based force probes 
DNA-based force probes, with easy adaptability and high uniformity, have seen 
increasing utilization in the study of mechano-transduction. Tension gauge tethers (TGT) 
 13 
was developed to tether ligands to the substrate by a double-stranded DNA that has a 
defined tension tolerance for rupture (48, 49) (Figure 4A). The tension tolerance can be 
designed at a low (unzipping the helix), high (shearing the strands), or intermediary 
(combination of both) level and fine-tuned by adjusting the length and G-C contents within 
a force range of 12–56 pN. Rupture of the TGT by the above tolerance forces, which are 
generated by the cell and applied through the receptor–ligand bonds, is irreversible and it 
reduces the availability of the tethered ligands, thereby inhibiting force-dependent cellular 
functions, such as spreading, migration, or signaling. By observing cell behaviors on TGT-
tagged ligands with different tension tolerances (12-56 pN), the minimum force that the 
cell can exert on single ligands and the threshold force required by such cell functions can 
be identified. 
Molecular tension-based fluorescence probes use a DNA hairpin, which unfolds under 
force but refolds upon force removal, instead of a double-stranded DNA that ruptures 
irreversibly by force. The two feet of the hairpin are conjugated with a fluorophore-
quencher pair, which prevents fluorescence from the fluorophore when the hairpin is folded 
but allows fluorescence when the hairpin is unfolded, thereby reporting the above threshold 
force exerted on the ligand (50-52) (Figure 4B). Since unfolding and refolding of the DNA 
hairpin are reversible, molecular tension-based fluorescence probes, which have a force 
range between 4–16 pN, can be used to visualize the spatiotemporal distributions of cell-
generated tensions on the receptor–ligand bonds and can be combined with other advanced 
imaging techniques, such as super-resolution nanoscopy in the future to visualize force 
generation at a single molecule level. 
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More recently, the sensitivity of the DNA-based force probes are enhanced by 
immobilizing DNA hairpins on gold nanoparticles, allowing the fluorophore on the hairpin 
to be dual-quenched by both the molecular quencher and gold nanoparticle to yield ~100-
fold higher signal/noise ratio due to the much lowered background (51). Ligand immobility 
can be overcome by anchoring probes on supported lipid bilayers with clustering controlled 
using a second un-quenched fluorophore (Figure 4C) (53), making these probes ideal for 
studying the distribution of force by specific receptors at cell-membrane interface where 
ligands and receptors can move laterally. Collectively, DNA-based probes are versatile 
tools to limit and visualize tensions on individual receptor–ligand bonds on the cell surface.  
 
Figure 4 – DNA-based force probe designs. (A) Tension gauge tethers (TGT). DNA 
strands with defined tension tolerances are repurposed to test the tension required to 
activate cell adhesion. (B) Molecular tension-based fluorescence microscopic probe. The 
fluorophore and quencher are coupled to report the force-induced unfolding of the DNA 
hairpin, thereby unquenching the fluorescence to report molecular forces. (C) Gold 
nanoparticle-based ratiometric tension probes on supported lipid bilayer monitor hairpin 
opening due to force while controlling for clustering of mobile ligands using a secondary 
fluorescent readout. 
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CHAPTER 3. MATERIALS AND METHODS 
3.1 Proteins, antibodies, and chemicals 
3.1.1 Proteins 
Mouse 2C TCR extracellular domain with a biotin-tag at its N terminus and mouse 
CD3γε extracellular domain with a biotin-tag at its C terminus were produced in High Five 
cells using baculovirus by Dr. Christopher Garcia’s lab (Stanford University). The 
constructs for extracellular domains of CD3ε (residues 23-106, counting from the start of 
the leader sequence) and CD3γ (residues 23-109) included the Ig domain and conserved 
extracellular CxxCxE motif. To ensure proper CD3 chain pairing, the C-terminus of the 
CD3ε and CD3γ extracellular domains were fused to an acidic and basic GCN4 zipper (54), 
respectively. Each chain also contained a C-terminal hexahistidine tag for purification, 
while the CD3ε construct also contained a C-terminal biotin acceptor peptide (BAP) 
sequence for site-specific biotinylation. The constructs of extracellular domains of the 2C 
αβTCR (1-213 for 2C TCRα, 1-247 for 2C TCRβ, as numbered in Garcia et al 1996 (20)) 
containined both Ig domains in each chain and the conserved cysteine that forms an 
interchain disulfide bond. To ensure proper orientation relative to CD3, the BAP sequence 
was placed on the N terminus of the TCRα extracellular domain. Following protein 
expression and purification, 2C TCR and CD3εγ were each site-specifically biotinylated. 
Purified proteins of human TCR, human CD3ge, human CD3de and mouse CD3ge 
extracellular domains were produced by Dr. Michelle Krogsgaard’s lab (New York 
University). 2B4 TCR constructs (both a and b subunits) contained constant domains from 
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human LC13 TCR with N-terminal and C-terminal biotinylation sequence. The constructs 
for ectodomain human CD3ge and CD3de subunits (55, 56), wherein the two subunits are 
linked by a 26-residue linker, were obtained from Dr. McCluskey and Dr. Kjer-Nielson 
from University of Melbourne (56). The mouse CD3ge subunit construct (57), with a 26-
residue linker, was obtained from Dr. Reinherz from Harvard University. N-terminal and 
C-terminal biotinylation sequence were added through PCR by using primers encoding the 
biotinylation sequence. Soluble proteins were generated by E. coli inclusion body 
expression, protein refolding and purification as previously described (58).  
Recombinant pMHC monomers were from the National Institutes of Health 
Tetramer Core Facility at Emory University. For analysis of OTI DP thymocytes, the 
following peptides were synthesized and presented by mouse MHC class I H2-Kb or its 
mutant H2-Kbα3A2 (replacing the mouse α3 domain by that of human HLA-A2): chicken 
ovalbumin-derived peptide OVA257-264 (SIINFEKL, agonist and negative selecting ligand) 
and its altered peptides (59) Q4 (SIIQFEKL, weak agonist and negative selecting ligand), 
Q4R7 (SIIQFERL, weak agonist and negative selecting ligand), T4 (SIITFEKL, weak 
agonist and negative selecting ligand), Q4H7 (SIIQFEHL, weak agonist and positive 
selecting ligand), Q7 (SIINFEQL, weak agonist and positive selecting ligand), and G4 
(SIIGFEKL, weak agonist/antagonist and positive selecting ligand) as well as endogenous 
peptides F-actin capping protein A-derived Cappa192-99 (ISFKFDHL, positive selecting 
ligand) (60, 61) and β-catenin-derived Catnb329-336 (RTYRYEKL, positive selecting 
ligand) (61). In addition, vesicular stomatitis virus-derived nucleoprotein VSV52-59 
(RGYVYQGL) bound to H2-Kb was prepared in the same way as noncognate ligand to test 
CD8 binding.  For the 2C TCR, SIYR (SIYRYYGL, super agonist and negative selecting 
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ligand), dEV8 (EQYKFYSV, agonist and positive selecting ligand), EVSV (RGYVYQEL, 
antagonist and positive selecting ligand), and p2Ca (LSPFPFDL, weak agonist and 
endogenous positive selecting ligand) peptides were bound to H2-Kb or H2-Kbm3 (two 
mutations in α1 domain, Asp77Ser and Lys89Ala (62)) (63-66). All pMHC monomers 
were engineered to have a biotin tag on the α chain C-terminus. 
3.1.2 Antibodies 
Rat anti-mouse CD53 (OX-79), anti-mouce CD4-APC (RM 4-5), anti-mouse 
CD8a-PE (53-6.7), anti-mouse Va 2 TCR-PE (B 20.1), anti-mouse TCRb-PE (H57-597), 
anti-mouse TCRb (H57-597), anti-mouse TCR Vb8 (F23.1) anti-mouse Va 11.1, 11.2 
TCR-PE (RR8-1), and anti-mouse TCR Vb8-PE (F23.1) were from BD Pharmingen. Anti-
human CD3-PE (UCHT1), anti-mouse CD3e-PE (145-2C11), anti-mouse/rat MHC II (I-




ylamine) was from Santa Cruz Biotechnology. Anti-rat Kappa MicroBeads and MS 
Columns were from Miltenyi Biotech. MAL-PEG3500-SGA linker was from JenKem 
Technology (Beijing, China). ROCK inhibitor Y-27632 was from Sigma-Aldrich. 
Latrunculin A was from Abcam. 
3.2 Cells 
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OTI and 2C TCR transgenic mice were housed at the Emory University Department 
of Animal Resources facility and followed protocols approved by the Institutional Animal 
Care and Use Committee of Emory University. CD8.4 OTI transgenic mice were gifts from 
Dr. Alfred Singer (National Cancer Institute). OT1 transgenic mice with 6F knock-in 
mutation were gifts from Dr. Paul Love (National Institute of Child Health and Human 
Development). Pre-selected DP thymocytes (67) were purified from a mouse thymus with 
CD53- CD4+CD8+ thymocyte enrichment by magnetic bead immunoaffinity cell sorting 
(MACS) according to the manufacturer’s instructions (Miltenyi Biotec, San Diego, CA). 
In brief, thymocytes were first incubated with rat anti-mouse CD53 antibodies (BD 
Pharmingen) in MACS buffer (PBS without Ca2+ and Mg2+, 2mM EDTA and 0.5% BSA) 
for 15 minutes at 4°C. After washing, these thymocytes were incubated with anti-rat Kappa 
MicroBeads (Biotech) in MACS buffer for 15 minutes at 4°C. Following another washing 
step, these thymocytes were resuspended in 500 ul of MACS buffer and added to MS 
Column. CD53- cells that passed through the MS Column (Miltenyi Biotec) were collected 
for experimental uses. Since CD53 expression and positive selection strongly correlated, it 
was selected as a purification marker (68). 
17ab OT1 hybridoma and OT1 hybridoma with CxCP mutation were gifts from Dr. 
Nicholas Gascogine (National University of Singapore). Mouse 58-/- T cell hybridoma 
transfected with mutant 2B4 TCR constructs through retroviral transduction were gifts 
from Dr. Michelle Krogsgaard (New York University). 
3.3 Flow cytometry 
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Samples were incubated in 100 ul of FACS buffer (PBS without Ca2+, Mg2+, 5 mM 
EDTA, 2% FBS) containing 10 ug/ml of antibodies of interest to stain for 30 min in 4°C. 
Samples were then washed twice with 200 ul of FACS buffer and resuspended in 350 ul of 
FACS buffer for analysis using LSR II flow cytometry (BD Biosciences). Flow cytometric 
data were analyzed using FlowJo (TreeStar). 
3.4 2D kinetics assays 
3.4.1 Micropipette adhesion frequency assay 
The theoretical framework and detailed experimental procedures have been 
described previous (5, 69). To summarize, binding events of red blodd cells (RBCs) coated 
with controled density of the protein of interest or cell expressing the protein of interest 
were measured against another RBC coated with controled density of the interacting 
partner of the protein of interest at various contact times. Human RBCs from healthy 
donors were first biotinylated using different concentrations of biotin to vary the maximum 
level of surface proteins that can be coupled on each RBC. In the example of TCR-CD3 
interaction, after functionalizing these RBCs through incubation with saturating amount of 
streptavidin (SA) and washing, purified and biotin-labeled TCR and CD3 molecules were 
coated onto RBCs through biotin-SA coupling in a 30-minute incubation step followed by 
washing steps to eliminate uncoated proteins. 
 Surface densities of 2C TCR and CD3 molecules on the RBCs were quantified by 
flow cytometry using PE-labeled anti-mouse TCR Vb8 (Clone F23.1, BD Pharmingen) 
and PE-labeled anti-mouse CD3e (Clone 145-2C11, eBioscience), respectively. Surface 
densities of 2B4/LC3 TCR with human constant region and human CD3 molecules were 
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measured using PE Rat anti-mouse Vα11.1, 11.2 TCR (Clone RR8-1, BD Pharmingen) and 
PE anti-human CD3e (Clone UCHT1, eBioscience), respectively.  
In the example of TCR-CD3 interaction, two individual RBCs coated with TCR 
and CD3 molecules, respectively were aspirated by two apposing micropipettes and 
maneuvered by micromanipulation to precisely set up cell-cell contact with defined contact 
area and contact time and the presence or absence of adhesion events were detected by 
using RBC as an ultrasensitive force sensor (70) and denoted as 1 for adhesion and 0 for 
no adhesion over 50 contact cycle for each cell pair (Figure 5). The resultant adhesion 
frequency curve (Pa vs tc) shows a monotonic increase of adhesion frequency with 
increasing contact time then reaches a plateau. The shape of the curve can be fitted using a 
probabilistic kinetics model with the following equation assuming a single step first order 
reaction 
 𝑃" = 1 − exp	(−𝑚,𝑚-𝐴/𝐾"[1 − exp −𝑘344𝑡/ ] (1) 
where Pa is the adhesion frequency, mr and ml are the respective surface densities 
of the protein of interest and its interacting partner on the RBCs. Ac is the contact area, Ka 
is the 2D affinity in (um2), and koff is the off-rate (s-1). Since Ac and Ka cannot be separated 
from the curve fitting, they are lumped together as the effective 2D affinity, AcKa. 
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Figure 5 – Sample images showing cell-to-cell contact in micropipette adhesion 
frequency assay. (A) impinged cell contact, (B) a sample event showing the absence of 
adhesion, and (C) an event with adhesion. 
3.4.2 Biomembrane Force Probe force-clamp assay 
Detailed experimental procedures of a BFP force-clamp assay has been described 
previously (71). Briefly, BFP force-clamp assay measures single bond lifetime of 
interacting proteins in response to force. Biotinylated proteins were coated onto SA-
conjugated glass beads. Using the example of TCR-CD3 interaction, a probe bead (Figure 
6A) coated with TCR proteins was attached to a human RBC functionalized with biotin, 
which acted as an ultrasensitive force sensor with known spring constant preset to 0.3 
pN/nm (71). Similar to the micropipette adhesion frequency assay, the RBC and a target 
bead coated with CD3ge or CD3de were aspirated by two apposing micropipettes and 
brought to approach, impinge, and contact for a defined duration before the target bead was 
retracted (Figure 6B). Through tracking the edge between the glass bead and the RBC using 
a high-speed camera at 1000 fps, the magnitude of force sustained in the interaction was 
determined to picoNewton precision. In a force clamp experiment, the retraction of the 
bead was stopped once the interaction sustained a desired amount of force, and the force 
was sustained until bond rupture, with the total duration defining the lifetime of the 
interaction at that force level. Multiple measurement cycles generated bond lifetimes at 
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various force levels, and the results were plotted as average bond lifetime vs average force 
by binning of events based on force. 
 
Figure 6 – Force-clamp assay using biomembrane force probe. (A) Schematics of the 
BFP setup showing a biotinylated RBC aspirated by a micropipette. A probe bead (left) 
was placed on the apex of the RBC through biotin-SA interaction. A target bead (right) 
was aspirated by a second micropipette and aligned against the center of the probe bead to 
establish contact driven by piezoelectric translator. (B) Representative force trace during a 
measurement cycle where a lifetime event was detected at the set force level. 
3.4.3 BFP thermal fluctuation assay 
Thermal fluctuation mode was used to measure lifetime of protein-protein interaction 
in the absence of force (72). In this mode, the target bead (Figure 6A) was retracted till the 
impinging force was no longer present and the protein pairs were allowed to interact 
through thermal fluctuation. The association and dissociation of protein-protein 
interactions were identified from the reduction and resumption, respectively, of thermal 
fluctuation. Lifetime was measured as the duration from fluctuation reduction to 
resumption indicated by the analysis of standard deviation of the bead movement. 
Modeling the kinetic process as a single-step first-order dissociation of a single monomeric 
bond, the probability Pb of a bond formed at time 0 to remain intact at time tb is given by 
the equation 
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 𝑃7 = exp −𝑘344𝑡7 . (2) 
Taking a natural log to linearize the exponential component of the equation, the resultant 
ln(# of events with a lifetime ³ tb) vs tb plot was fitted by a straight line with the negative 
slope of the fitted line representing an estimate of the off-rate koff (29).  
3.5 Molecular stiffness analysis 
A detailed description of method to measure molecular stiffness was described 
previously (73). In brief, the slope of force vs. displacement curve obtained during the ramp 
phase of BFP measurements is the stiffness of the system, which is consisted of the stiffness 
of the cell and that of the molecular complex in series. As such, the reciprocal of the system 
stiffness, 1/kmol-cell, equals the sum of the reciprocals of the cellular and molecular stiffness, 
1/kcell + 1/kmol. Based on the assumptions of 1) molecular complex can resist tension but 
not compression, and 2) cellular spring has the same stiffness regardless of whether the cell 
surface is pulled or pushed, kcell and kmol-cell can be estimated from the respective slopes of 
force vs. displacement curve for compression and tension. The molecular stiffness was 
calculated using the equation kmol = 1/(1/kmol-cell – 1/kcell). 
3.6 DNA force probe 
All oligonucleotides were custom synthesized and purified by Integrated DNA 
Technologies. The design of the probe consisted of a ssDNA hairpin hybridized through 
two 21-mer DNA handles to the ligand and anchor strands. The 3’ terminus of the anchor 
strand was modified with an amine group (NH2) to immobilize the oligonucleotides on a 
functionalized surface, while the 5’ terminus of the ligand strand was modified with a biotin 
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group for ligand attachment through biotin-streptavidin interaction. Two different designs 
of DNA force probes were calibrated by BFP to measure F1/2 (the force at which 50% of 
hairpins unfold) of each hairpin and they were found to be 4.7 pN and 13.1 pN (Figure 7). 
These DNA force probes were functionalized on to MPTMS-treated glass surfaces using 
MAL-PEG3500-SGA linker (JenKem Technology) then linked to pMHC using biotin-
streptavidin interaction. Anti-mouse CD11a (LFA-1) antibodies were incubated together 
with the DNA force probes in a 1:10 ratio to facilitate anchoring of thymocytes on the glass 
surface. These anti-LFA-1 antibodies were not conjugated to DNA force probes and did 
not contribute to fluorescence signal. OTI thymocytes were injected onto the coverslips 
and allowed to settle for 5 minutes before imaging using a Zeiss LSM 710 confocal 
microscope at room temperature for maximum of 30 minutes. During these 30 minutes, 
either single snapshot of multiple spots containing thymocytes interacting with the 
functionalized surface or time lapse imaging of single cells for 9 minutes were performed. 
During Lck inhibition treatment, cells were allowed to settle onto the coverslip containing 
4 uM of Lck inhibitor for 5 minutes before imaging experiments in the presence of the 
inhibitor were performed. For other drug treatment experiments, the conditions were 20 
minutes of time lapse image with 5 minutes of imaging intervals on multi-position imaging 
module. Upon unfolding of the DNA hairpin, an increase in Cy5 emission intensity was 
detected due to the separation between the fluorophore and the quencher on the DNA force 
probe. Image analyses were performed using ImageJ. 
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Figure 7 - Calibration of DNA force probes. (A) Opening force F1/2 of 4 pN and 16 pN 
force probes measured by BFP. The values were determined at the point where half of the 
probes are open. (B) Representative unfolding event showing a drop of force level during 
the ramping phase of BFP. The dip in force level corresponded to a lengthening of construct 
under force as the DNA hairpin unfolded. 
3.7 Statistical analysis 
F-test was used in spring constant analysis to assess the goodness of fit of Gaussian 
distribution on a population of molecular spring constant values. Linear regression was 
performed on thermal fluctuation data sets to generate lines of best fit for the estimation of 
2D off-rates. Comparison between two groups of data were done using student’s t-test. 
One-way ANOVA was used for comparison between multiple groups of data. Data were 
represented as mean ± SEM unless otherwise stated. 
For force vs. lifetime data generated by BFP assay, catch-slip bonds were fitted with 
a single Gaussian distribution and different catch-slip bonds were compared against each 
other using a null hypothesis that one curve was needed for both data sets, and an 
alternative hypothesis that different curve was needed for both data sets. The null 
hypothesis was rejected when p was found to be less than 0.05 using F-test. 
F1/2 Analysis








































CHAPTER 4. KINETIC CHARACTERIZATION OF SPECIFIC 
INTERACTION BETWEEN TCR AND CD3 IN THE 
EXTRACELLULAR DOMAIN 
4.1 Introduction 
T lymphocytes play a central role in adaptive immune response against bacteria, 
viruses, toxins, and cancer cells (74). T cells recognize antigen in the form of peptide (p) 
presented on the major histocompatibility complex (MHC) expressed on the surface of 
APCs to discriminate pathogens from self-antigens (74, 75). Prior studies have indicated 
the affinity of TCR-pMHC interaction correlates with T cell responsiveness (3-5). Despite 
much effort in the field to investigate how T cell ligation leads to T cell activation, the 
exact mechanism is still poorly understood. One of the key reasons for this lies in the 
unique structure of the T-cell receptor (TCR)  complex. While pMHC is bound to the 
membrane distal domains of the a and b subunits of TCR, intracellular signaling events 
are mediated by CD3 dimers (CD3zz homodimer, CD3ge heterodimer, and CD3de 
heterodimer) that contain at least one conserved immunoreceptor tyrosine-based activation 
motif (ITAM) (8, 14, 76). As such, signaling initiation from pMHC engagement of the 
TCR has to be transmitted to CD3 through specific interactions between TCR and CD3. 
However, direct binding measurement of specific interaction between the extracellular 
domains of TCR and CD3 by 3D kinetics measurements such as Surface Plasmon 
Resonance (SPR) was not possible due to the estimated low affinity of this interaction (24, 
57) and other methods, such as the ones utilizing mutagenesis, were only able to elicit 
indirect results of this particular interaction (22). Recent studies have used nuclear 
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magnetic resonance (NMR) spectroscopy to identify TCR-CD3 interactions sites (26, 77) 
and small-angle X-ray scattering and EM to investiage the overall organization of the TCR-
CD3 complex (21). However, none of these studies were able to quantify and characterize 
the interaction amongst the different subunits of the TCR complex, which is critical for 
unraveling the triggering mechanism of TCR and its subsequent signal transduction during 
T cell activation. Mapping out the specific interactions amongst different components of 
the TCR complex not only serves to furhter our understanding on how T cell triggering 
relates to activation, but also plays an essential role in directing efforts toward discovering 
potential therapeutic targets capable of modulating T cell responses.  
The interplay between TCR and CD3 has been a topic of great interests over the last 
two decades. Cystal structure of TCR extracellular domain (20) and solution and crystal 
structures of the extracellular domain of CD3d, g, and e (24, 56, 57, 78) provided an 
excellent starting point in unraveling the structural basis of the TCR complex and the 
organization of its various components. Dimerization of TCR or clustering of TCR has 
been suggested as a key step in TCR signaling based on TCR or CD3 cross-linking studies 
(79-82). Another model on T-cell signaling involes conformational change of the TCR-
CD3 complex subunits with respect to each other and/or the membrane (25, 83). In relation 
to the conformational change model, a new line of studies that focus on the role of 
mechanical force in T cell activation have emerged on the field. The central hypothesis of 
these studies is that TCR-pMHC interactions formed across cell interface are likely 
subjected to mechanical forces (84-86) and the TCR-CD3 subunits move as a unit to 
undergo conformational change under the influence of mechanical force. In the 
‘mechanosensor’ model, it was proposed that TCR-pMHC interaction is capable of 
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generating a torque, resulting in the FG loop of TCR to act as a lever pressing on the 
extracellular domain of CD3e, which is thought to stiffen and transfer force through the 
membrane to generate downstream signaling (16, 57, 87). More recently, one study has 
demonstrated that force can prolong the lifetime of TCR-pMHC interaction for agonistic 
peptides (13), while another showed that T cell ligation may lead to actin polymerization 
and generation of protrusive forces (12). Theses studies highlighted the relevance and 
importance of force as a potential regulator of T cell response. It seems reasonable to 
hypothesize that since mechanical force influences TCR-pMHC interaction at the site of 
triggering, the immediate next link, TCR-CD3 interaction, is likely subjected to force upon 
antigen engagment and the ability of CD3 to transfer force signal from TCR plays a key 
role in signal initiation of the TCR complex.  
In this study, I measured the 2D kinetics (69) of the specific interactions between the 
extracellular domains of mouse and human TCR and CD3 in vitro, and used Biomembrane 
Force Probe (BFP) (71) to investigate TCR-CD3 interaction under force. Measurements of 
specific interactions between TCR and CD3 ectodomains allowed us to provide insight on 
the arrangement of the members within the TCR complex and the molecular mechanism 
for dimerization of TCR-CD3. Theses findings on the enhancement of TCR-CD3 
interaction under force strengthened the role of CD3 as a force transducer and redefine the 
model of TCR early triggering by providng a more complete picture on howTCR-pMHC 





4.2.1 Characterization of 2D kinetics of mouse TCR-CD3 extracellular domains revealed 
specific interaction 
To address the gap of knowledge revolving around the presence of specific 
interaction between TCR and CD3 in the extracellular domains, I first tried to determine 
whether the extracellular domain of mouse 2C TCR and CD3ge interact by assessing the 
2D kinetics of these two proteins using the micropipette adhesion frequency assay. Since 
TCR and CD3ge interact through cis-interactions on a single cell membrane under 
physiological conditions, I tried to simulate this orientation to my best capabilities by 
orientating the 2C TCRs via its N-terminus and CD3ge via its C-terminus on separate RBCs 
(Figure 8A). As such, when the two RBCs were brought into contact, TCR and CD3ge 
assumed a “pseudo-cis” orientation similar to the physiological conditions. Non-specific 
interactions were controlled through measuring the adhesion frequency between the protein 
of interest (2C TCR or CD3γε) with streptavidin-coated RBCs, and negligible level of 
adhesion was detected for both cases (Figure 8B). 
As shown in Figure 8C, the effective 2D affinity between mouse 2C TCR and 
mouse CD3γε was determined to be 3.4x10-5 um4. At the same time, specific homotypic 
interaction of CD3γε was also measured using CD3ge orientated through its N-terminus on 
one RBC and through its C-terminus on the other RBC. The effective 2D affinity of CD3ge 
homotypic interaction was determined to be 2.3x10-5 um4. The off-rates of these 
interactions were measured by thermal fluctuations assay to be 12.8 s-1 for TCR-CD3ge 
and 8.3 s-1 for CD3ge homotypic interaction. Adhesion frequencies at various contact times 
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were measured for the 2C TCR-CD3ge interaction (Figure 8D) and CD3ge homotypic 
interaction (Figure 8E), while non-specific interaction is shown in black in the same graph. 
 
Figure 8 – 2D kinetics of mouse TCR-CD3 interaction. (A) Micropipette setup showing 
orientation of purified TCR and CD3. (B) direct comparison of adhesion frequency 
between mouse 2C TCR and mouse CD3ge, mouse CD3ge homtotypic interaction, mouse 
2C TCR homotypic interaction versus that of the non-specific controls (streptavidin-coated 
RBCs versus itself and the proteins of interests). (C) Summary of 2D effective affinity and 
off-rate of mouse 2C TCR-CD3ge interaction and mouse CD3ge homotypic interaction. 
(D) Mouse 2C TCR-CD3ge adhesion curve, and (E) mouse CD3ge-CD3ge adhesion curve. 
Adopting a similar “pseudo-cis” orientation, the interaction between extracellular 
domain of 2B4 TCR expressed with human constant region and human CD3ge and CD3de 
were assessed using the micropipette assay, and specific interactions were detected (Figure 
9A). The 2D effective affinity between human TCR constant and human CD3ge was 
3.4x10-6 um4 and that for CD3de was 2.1x10-6 um4. Interplay between human CD3 dimers 
was investigated and specific interactions were measured for each of the different 
combinations. CD3ge-CD3de heterotypic interaction had the highest 2D effective affinity 
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(1.1x10-5 um4) amongst heterotypic interactions. In terms of homotypic interactions, 2D 
effective affinity was 6.6x10-6 um4 for CD3ge and 2.0x10-4 um4 for CD3de, and 2.6x10-6 
um4 for TCR.  
Off-rates of TCR-CD3ge and TCR-CD3de were measured by thermal fluctuation 
assay to be 14.1 s-1 and 11.1 s-1, respectively (Figure 9B). Off-rate of CD3ge–CD3de 
heterotypic interaction was found to be 14.9 s-1. 
It is worth noting that crosstalk between human CD3 and mouse TCR was not 
observed, as no adhesion event was detected between these two proteins.  
These observations (Table 1) strongly suggest the presence of a specific binding 
site between the extracellular domains of TCR and CD3ge subunits. Furthermore, the 
homotypic and heterotypic interactions observed between CD3 subunits could play a 
relevant role in the formation of multimers of TCR-CD3 complex as the presence of 




Figure 9 - 2D affinity of human TCR-CD3 extracellular interactions. (A) 2D affinity 
of heterotypic and homotypic extracellular interactions amongst members of the human 
TCR complex. (B) Comparison of 2D effective affinity and off-rate of human TCR-CD3ge, 
human TCR-CD3de, and CD3ge-CD3de interactions. Data are mean ± SEM. 
Table 1 - Summary of 2D kinetics of TCR-CD3 interactions 
 2D AcKa (um4) 2D koff (s-1) 2D AcKon (um4s-1) 
2C TCR vs mCD3ge 3.38 ± 0.87 x 10-5 12.8 ± 0.28 4.33 ± 1.12x10-4 
mCD3ge vs mCD3ge 2.33 ± 1.53x10-5 8.83 ± 0.32 2.06 ± 1.35x10-4 
hTCR vs hCD3ge 2.56 ± 0.69x10-6 14.1 ± 0.15 3.62 ± 0.98x10-5 
hTCR vs hCD3de 2.10 ± 0.70x10-6 11.1 ± 0.48 2.34 ± 0.79x10-5 
hCD3de vs hCD3de 1.10 ± 0.44x10-6 14.9 ± 0.37 1.64 ± 0.66x10-5 
 
























































































4.2.2 FG loop has a major contribution to TCR-CD3 extracellular interaction 
The FG loop on TCRb constant region has been implicated as one of the key sites 
of interaction between TCR and CD3 in various studies (16, 19).  Therefore, I blocked this 
interaction by H57-597, which is an antibody targeting the FG loop on the murine TCRb 
(19). In the presence of H57-597, the adhesion frequency between 2C TCR and CD3ge 
dropped significantly from 37% to 6% (Figure 10A), thus confirming the importance of 
the FG loop in mediating specific interactions between TCR-CD3 extracellular domain. 
Similarly, the 2C11 antibody that binds to mouse CD3e reduced the adhesion frequency 
from 59% to 8% when present during the assay (Figure 10B). However, it is worth noting 
that the level of adhesion did not get abolished completely in the presence of either 
antibody, indicating that there might be other sites of interaction between TCR and CD3ge 
distinct from the FG loop, such as the Ca DE loop and Cb CC’ loops (6). As a negative 
control, F23.1 antibody targeting the variable region of TCRb did not cause a significant 
drop of adhesion frequency after blocking (Figure 10C), suggesting that the presence of 
antibody alone does not lead to reduction in binding. Blocking with H28-710 antibody, 
which binds to the constant region of mouse TCRa (88), also did not lead to a drop in 
adhesion frequency (Figure 10D). The results so far strongly suggest that the region 
targeted by H57-597, which includes the FG loop, is a major contributor to the TCR-CD3ge 
interaction observed.  
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Figure 10 – The effect of antibody blocking on the adhesion frequency between mouse 
2C TCR-CD3ge interaction. (A) H57-597 antibody blocking and (B) 2C11 antibody 
blocking resulted in a significant decrease in adhesion frequency, p < 0.05. (C) F23.1 
antibody blocking and (D) H28-710 antibody blocking did not lead to a significant decrease 
in adhesion frequency. Results were analyzed by student’s t test. Data are mean ± SEM. 
4.2.3 TCR-CD3 interaction exhibits a catch-slip behavior under force 
A recent study from the Zhu lab demonstrated a role for mechanical force on TCR-
pMHC interaction and found that TCR interaction with agonist pMHCs can be prolonged 
under force till a peak force level around 10 pN (13). As a bridge between TCR-pMHC 
recognition and initiation of intracellular signaling, CD3 is likely subjected to force as a 






















































































































contribution of mechanical force in mediating TCR-CD3 interaction. A biomembrane force 
probe (BFP) assay was used to measure the lifetime of interaction between 2C TCR and 
CD3ge at various clamp forces (Figure 11A, B), and the resultant lifetime vs. force curve 
displayed a catch-slip behavior (Figure 11C). As the clamping force between TCR and 
CD3 increased from 0 pN to 10 pN, the lifetime of TCR-CD3ge interaction increased with 
increasing force, and this characteristic is typically called the ‘catch-bond’. The peak 
lifetime occurred at around 10 pN, and beyond this force level, lifetime of interaction 
decreased with increasing force, and this characteristic is termed ‘slip-bond’. CD3ge 
homotypic interaction also displayed a catch-slip behavior, albeit much less pronounced 
than TCR-CD3ge interaction (Figure 11C). In comparison, the force at which peak lifetime 
occurred for TCR-CD3ge interaction coincided with that of the interaction between naïve 
2C TCR and agonist pMHC SIYR (Figure 11C). This finding suggests that the force 
experienced by TCR-pMHC is likely transferred to TCR-CD3 interaction, as both 
interactions are enhanced to their maximal values (longest bond lifetime) at very similar 
force range (~ 10 pN). 
 
Figure 11 – Mouse TCR-CD3 interaction exhibits ‘catch-slip’ behavior under force. 
(A) Schematics of the BFP setup showing a biotinylated RBC aspirated by a micropipette. 
A probe bead (left) was placed on the apex of the RBC through biotin-SA interaction. A 
target bead (right) was aspirated by a second micropipette and aligned against the center of 
the probe bead to establish contact driven by piezoelectric translator. (B) Representative 
force trace during a measurement cycle where a lifetime event was detected at the set force 
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level. (C) Lifetime versus force curves showing that mouse 2C TCR-CD3ge extracellular 
interaction exhibits ‘catch-slip’ behavior (blue) with a peak lifetime occurring at 
approximately 10 pN, which coincide with that between naïve 2C TCR versus SIYR 
pMHC (pink, adapted from (13)). CD3ge homotypic interaction displayed a less 
pronounced catch slip behavior (red). Curves were fitted with Gaussian distribution, and 
significant differences were found between TCR vs CD3 and CD3ge homotypic interaction 
curves and between 2C TCR vs SIYR and CD3ge homotypic interaction curves (p < 0.05). 
Data are mean ± SEM. 
Similar to mouse TCR-CD3ge interaction, human TCR-CD3 interactions displayed 
catch-slip behavior for both TCR-CD3ge and TCR-CD3de (Figure 12). The force at which 
peak lifetime occurred was ~15 pN for both CD3de and CD3ge. Lifetime was increased to 
seven times its zero-force value for TCR-CD3de and five times its zero-force value for 
TCR-CD3ge at their peaks. CD3 heterotypic interaction showed a less pronounced catch-
slip behavior with significantly lower lifetime at various force levels compared with TCR-
CD3 interactions. The findings from human TCR-CD3 interactions corroborate well with 




Figure 12 - Human TCR-CD3 extracellular interactions under force exhibit ‘catch-
slip’ behavior for TCR-CD3ge (blue), TCR-CD3de (red), and CD3ge-CD3de (black). 
Curves were fitted with Gaussian distribution, and significant differences were found 
between TCR vs CD3ge and CD3ge-CD3de heterotypic interaction curves and between 
TCR vs CD3de and CD3ge-CD3de heterotypic interaction curves (p < 0.05). Data are mean 
± SEM. 
4.2.4 Mutations affecting TCR-CD3 extracelluar interaction can impact TCR-pMHC 
recognition 
Previous NMR studies (26) identified potential interaction sites for CD3ge and 
CD3de on the 2B4 TCR constant region and when specific mutations were introduced in 
these sites and expressed in T cells, they caused a decrease in T cell function upon 
activation with pMHC indicating that the identified interaction sites were functionally 
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relevant. To determine and quantify the effect of these specific mutations on binding 
affinity of the extracellular interaction between mutant TCR and CD3ge, I measured the 
kinetics of the interaction between CD3 subunits and the WT TCR and mutants 
(N205AH206A, N180AQ191A, and Q138AK139A) (26) using the micropipette adhesion 
frequency assay. Interestingly, I observed comparable 2D effective affinity in the presence 
or absence of these point mutations (Figure 13A). However, when I measured the lifetime 
of these interactions at various forces, the results showed a catch-slip behavior for TCR 
NH-CD3ge and a less pronounced catch-slip behavior for TCR E133AI134A (EI)-CD3ge 
(Figure 13B). In comparison with wildtype (WT) TCR, these mutant TCRs showed a lower 
peak lifetime occurring at a lower force (Figure 13B). TCR EI, which showed the lowest 
IL-2 production (26), had the lowest magnitude of lifetime at peak level. The correlation 
between the weakening of TCR-CD3 extracellular interaction under force for mutant TCRs 
and the reduction in functional outcome from cells expressing these mutant TCRs strongly 
suggests that TCR-CD3 extracellular interaction serves as a link from TCR-pMHC 
recognition signal to intracellular signaling response, and a disruption of TCR-CD3 
extracellular interaction is likely going to impact intracellular signaling adversely. 
To strengthen my hypothesis that TCR-CD3 extracellular interaction plays a key 
role in relaying signaling from pMHC recognition to T-cell signaling initiation, I tested the 
impact of TCR mutations on pMHC recognition using hybridoma cells expressing these 
TCR mutants. Adhesion frequency vs contact time curve was measured for WT TCR to 
establish the contact time required for the interaction to reach a plateau (i.e. no further 
increase in adhesion frequency with increasing contact time) (Figure 14A). As a result, I 
used 3 second contact time to measure the 2D effective affinity of the other TCR mutants. 
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Similar to findings on TCR-CD3 interaction, these TCR mutants showed no significant 
change on TCR-pMHC affinity as the effective affinities measured against I-Ek/k5 was 
comparable for GK, N136A and NP mutants and WT (Figure 13C). The lack of change in 
TCR-pMHC affinity as a result of TCR mutation did not correlate with trend previously 
reported using IL-2 as a readout of functional outcome (26). To obtain an adhesion 
frequency of ~20% to affirm the condition for >90% single bond lifetime measurements 
(69), I optimized surface density of pMHC and determined 0.1 second contact time to be 
used for lifetime measurements (Figure 14B). Under force, the WT TCR and the three 
mutant TCRs all displayed catch-slip behavior with peak lifetime correlating with the 
functional outcome previously quantified (26). For instance, the NP mutant, which was 
found previously to have an increase in IL-2 production of ~32% relative to WT, showed 
an increase of peak lifetime by ~29%. While the N136A mutant, which was found to have 
a decrease in IL-2 production of 25% relative to WT, showed a decrease of peak lifetime 
by ~53% (Figure 13D). The agreement between the magnitude of peak lifetime and IL-2 
production strongly suggests a close tie between the strength of TCR-pMHC interaction 
under force and the functional outcome of cells expressing these TCRs. Furthermore, even 
though these mutations were made on the constant region of TCR to affect its interaction 
with CD3 subunits, they had a direct impact on TCR-pMHC interaction despite being 
remote from the pMHC recognition site. Taken together, these findings provide strong 
evidence of TCR-CD3 extracellular interaction serving as a critical link in the transduction 
of pMHC recognition signal to the outcome of early TCR signaling, and a disruption to 
this critical link can affect TCR recognition of pMHC. 
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Figure 13 – TCR-CD3 and TCR-pMHC interactions affected by mutations on TCR 
constant region. (A) Mutations on the extracellular domain of TCRb constant region (NH, 
NQ, and QK) did not lead to a significant change to the 2D effective affinity. (B) Lifetime 
versus force curves showing TCR NH and TCR EI form catch-slip bonds with human 
CD3ge, and in comparison to WT TCR, the catch-slip bonds formed between MT TCR and 
CD3ge have peak lifetime occurring at a lower force, and the magnitude of the catch-slip 
bond is lower in TCR EI compared with TCR NH. Curves were fitted with Gaussian 
distribution, and significant differences were found between WT TCR vs CD3ge and TCR 
NH vs CD3ge interaction curves and between WT TCR vs CD3ge and TCR EI vs CD3ge 
interaction curves (p < 0.05). (C) Mutations on the extracellular domain of TCRb constant 
region (NP, GK, and N136A) led to no change of 2D affinity between TCR and pMHC 
loaded with I-Ek/k5. (D) Mutations in (C) led to a shift in bond lifetime of TCR against I-
Ek/k5 under force. Curves were fitted with Gaussian distribution, and significant 
differences were found between NP and WT, NP and N136A, NP and GK, WT and N136A, 
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Figure 14 – Adhesion frequency control using beads coated with SA against T cell 
hybridoma expressing WT and mutant TCRs. (A) Adhesion frequency vs time curve of 
hybridoma expressing WT TCR interaction with pMHC loaded with I-Ek/k5 (blue) and 
with beads coated with SA (black). (B) Adhesion frequency comparison between non-
specific control (vs beads coated with SA) and specific interaction against I-Ek/k5 at 0.1 
second contact time. Conditions were optimized to attain ~20% adhesion frequency for 
lifetime measurements using BFP. Data are mean ± SEM. 
4.3 Discussion 
Findings from this study have demonstrated the presence of specific interaction 
between TCR and CD3 in the ectodomain through direct measurement in both mouse and 
human systems. In comparison with mouse TCR binding affinity with agonist pMHCs, 
which resides in the region of 10-4 um4 in general, the observed TCR-CD3ge interaction 
and CD3ge homotypic interaction are two orders of magnitude lower and thus considered 
weak interactions. This could explain why such interactions were not detectable using other 
methods such as SPR (24). Nevertheless, our sensitive assays have shown that these TCR-
CD3 interactions indeed exist.  
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The presence of ectodomain heterotypic CD3 interactions suggests a potential role of 
such interactions in facilitating and stabilizing the dimerization of TCR complex, as 
suggested in a prior EM-based study (21), which proposed a model where CD3 subunits 
are situated at the center of the dimer with TCRs that are engaged with pMHC on the 
outside forming an angle with respect to one another. Although these data do not provide 
definitely proof on the exact orientation of the CD3 subunits around TCR, the potential 
stabilization effect of dimeric TCR from CD3-CD3 extracellular interactioin is a possible 
reason for the existence of such an interaction. 
Antibody blocking of the FG loop on mouse TCR beta chain significantly reduced the 
adhesion frequency between TCR and CD3ge, suggesting a major contribution of the FG 
loop in mediating the extracellular interaction between TCR and CD3. These data therefore 
support the results of previous studies where potential TCR-CD3 binding sites were 
proposed based on the crystal structure of abTCR with H57-597 Fab and results from 
antibody blocking experiments (19). Furthermore, deletion of the FG loop was found to 
reduce functional sensitivity of TCR-mediated activation (89), signifying the importance 
of the FG loop in signal transduction. However, since the antibody did not completely 
abolish the interaction between TCR and CD3, it is still possible for there to be other 
extracellular binding sites between TCR and CD3, albeit having minor contribution in 
comparison with the FG loop.  These findings are not exhaustive, other candidates, such as 
the AB loop of the TCR Ca domain, which has been proposed to regulate TCR 
dimerization (90), can be worthwhile targets for future studies investigating the effect of 
point mutations in the AB loop on TCR-CD3 and even TCR-TCR affinities.  
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Findings presented in this study support the concept that force is critical in T cell 
triggering and early signaling. Force from actin retrograde flow and myosin-II dependent 
contraction may be transmitted to TCR bound to anchored pMHC molecules (10), and 
formation of immunological synapses and kinapses (11, 12, 91). Internal force generated 
by T cells have been visualized to exert on TCR via engaged pMHC molecules (51, 53). 
In addition, previous studies (13, 92) have demonstrated the force-dependent kinetics of 
TCR-pMHC interactions using preTCR and mature abTCR, and identified the optimal 
condition at which the lifetime of TCR-pMHC interaction is the longest, leading toward 
more effective T cell triggering. In naïve OT1 T cells, TCR was found to form a ‘catch-
slip’ bond with agonist pMHCs with an optimal force occurring around 10 pN where the 
lifetime of TCR-pMHC interaction was found to be the longest before a further increase in 
force began to decrease bond lifetime (13). This unique ‘catch-slip’ behavior was only 
observed in agonistic pMHCs, which could provide a good criterion for separating agonist 
pMHCs from those with less biological activities, thus aiding TCR discrimination of 
peptides using the duration of TCR-pMHC interaction under force as a readout. My 
findings integrate well with the aforementioned study, as they are able to provide insight 
to the event that occurs immediately following TCR-pMHC interaction, which is the 
transduction of signal from TCR to the surrounding CD3 subunits in the extracellular 
domain. The pulling force experienced by the TCR-pMHC interaction is likely relayed to 
the surrounding CD3 subunits, as evidenced by the prolonged TCR-CD3 lifetime at the 
same optimal force (10 pN), where the strongest calcium ion flux was triggered in T cells 
(13). Furthermore, the findings on TCR-CD3 interaction under force show similar trend 
for both mouse and human systems, although the peak lifetime occurs at a higher force 
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(~15 pN) for the human proteins, which could be due to the difference in human TCR-
pMHC interaction profile under force, a topic that warrants further investigation. A 
mechanosensing model of TCR was previous proposed (85), which describes the activation 
of abTCR by mechanical force through pushing on the CD3e. Although not directly 
supported by findings in this study, which primarily involve tensile forces along the 
interface between TCR and CD3 in the extracellular domain, the importance of a relative 
positional shift between TCR and CD3 could lead to the same effect of phosphorylation of 
ITAMs on the cytoplasmic tails of CD3 subunits, as described by the mechanosensing 
model.  
The functional importance on the force-dependent interaction between TCR and CD3 
in the ectodomain is highlighted by findings from introducing various point mutations in 
previously identified TCR-CD3 interaction sites (26). While force-free kinetics between 
the mutated TCRs and CD3ge molecules failed to correlate with the amount of IL-2 
produced upon stimulation when these mutants were expressed in T cells, the magnitude 
of the catch-slip bond formed by these mutant TCRs with CD3ge showed a more telling 
change with the lowest IL-2 producer (EI mutant) corresponding to the lowest TCR-CD3ge 
peak lifetime under force. These findings suggest that despite the similarity in the affinities 
of TCR-CD3ge interaction of the various TCR mutants under force-free conditions, the 
ability to prolong interaction under force plays a critical role in dictating downstream 
responses. Furthermore, these findings showed that even though the locations of these TCR 
mutations occur in the constant region of the TCR, they can impact the peak lifetime of 
TCR-pMHC interaction with the magnitude of peak lifetime under force correlating well 
with IL-2 production upon antigen stimulation as shown previous (26). Despite the fact 
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that these mutations do not affect TCR recognition of pMHC directly, these findings are 
unexpected at first glance, but reconcilable, considering the hypothesis that TCR-CD3 
extracellular interaction play the role of a relay in the transduction of pMHC recognition 
signal to intracellular signaling.   
Based on previous kinetics studies on the force-dependent nature of TCR-pMHC 
interaction (13, 93) and my current work, I propose the following model of early TCR 
signal transduction. Upon engagement with agonist pMHC, the formation of TCR-pMHC 
catch bond exerts a shearing force along the interface between TCR and CD3 in the 
ectodomain, resulting in a pulling of CD3 subunits in a direction away from the membrane. 
The formation of TCR-CD3 catch bond selectively prolongs lifetime of this interaction 
while TCR is engaged with agonist pMHCs. The prolonged lifetime on CD3 under force 
permits the transduction of mechanical force across the membrane, which then leads to the 
swing out of CD3 cytoplasmic tails away from the plasma membrane (27) through possibly 
force-dependent conformational changes. The exposed CD3 tails allow the 
phosphorylation of ITAMs by Lck and the subsequent recruitment of Zap70 to 
phosphorylated ITAMs to initiate other downstream signaling events (94). 
Collectively, my findings provide direct evidence to the existence of TCR-CD3 
extracellular interaction and the role of such interaction in the transduction of signal from 
the extracellular arm (TCR-pMHC recognition) to the intracellular arm (early TCR 
signaling) of the TCR complex. The whole mechanism of how exactly pMHC recognition 
signal leads to intracellular signaling is by no means solved, as further insights are required 
on the transmembrane portion and the intracellular portion of the TCR complex in response 
to force-dependent triggering. Nevertheless, this study is able to fill in an important gap of 
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knowledge on the extracellular portion of the puzzle and move the field closer toward 





CHAPTER 5. THE CONTRIBUTION OF LCK-DEPENDENT 
TCR-PMHC-CD8 TRIMOLECULAR INTERACTION IN 
THYMOCYTE SELECTION 
(Disclaimer: The following work was done in collaboration with Dr. Jinsung Hong (Co-
first author). Manuscript in preparation.) 
5.1 Introduction 
T cell recognition occurs based on the molecular interaction between T cell receptors 
(TCRs) displayed on the surface of responding T cells and antigen peptides bound to the 
major histocompatibility complexes (pMHCs) expressed on antigen presenting cells 
(APCs). In addition, the invariant CD4 or CD8 coreceptors co-ligate TCR-bound pMHC 
class II or I molecules, respectively, to provide T-cell specificity (43, 47, 95). This 
trimolecular interaction is highly elegant in that it does not merely result in an all-or-none 
response; rather, the responding T cell interprets the information presented by the pMHC, 
translating the complex input into a broad set of phenotypic outcomes. Since it is vital for 
T cell recognition, kinetics, structural, and functional studies (41, 42, 47) have been 
devoted to this molecular interaction. However, our current understanding still is 
incomplete in how these three molecules interact in situ and how such interactions drive T 
cell function and developmental fate.  
Kinetics studies on the TCR-pMHC-CD8 trimolecular interaction so far have been 
carried out under force-free conditions, using either 3D assays (42, 46) or 2D micropipette 
adhesion frequency assay (47). Recently, increasing evidence has drawn attention to the 
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role of mechanical force in TCR–pMHC interaction (11, 86). The role of mechanical force 
on T-cell activation has been a keen interest since a few surface-bound antigens, unlike 
soluble form, were able to trigger T-cells (96). Further studies showed TCR-CD3 complex 
is sensitive to the length of the ligands, such that elongated ligands triggered TCR poorly 
(17), and rigidity of the surface (97), and calcium signaling was dependent on the 
mechanical force on TCR or CD3 (16, 17, 98). In addition, traction force from TCR-CD3 
complex has been observed using elastomer pillar arrays (99). Our lab recently showed that 
mechanical force regulates TCR–pMHC dissociation kinetics in a peptide-dependent 
manner to amplify peripheral T-cell discrimination and trigger calcium signaling (13, 100, 
101). Findings from our lab revealed two types of bonds for these interactions: 
counterintuitive catch bonds where force prolongs their lifetime and ordinary slip bonds 
where force shortens their lifetime. Furthermore, T-cells showed a ligand dependent 
generation of pulling force in the presence of CD8 coreceptor, providing the support for 
the physiological relevance (51). 
Based on these previous data that the mechanical force on the TCR and coreceptor 
is critical for physiological T cell signaling and self vs. non-self discrimination (13, 51, 53, 
100, 101), we hypothesize that a major way for force to exert its effect is through the 
modulation of kinetics of pMHC bonds with TCR and/or CD4/8 for T cell function and 
development of T-lineage cells. To test this hypothesis, we measured force-dependent 
lifetimes and molecular stiffness of pMHC bonds with TCR and/or CD8 on thymocytes 
using a biomembrane force probe (BFP) to determine the quality of bonds (73), in addition 
to measuring the quantity of bonds at zero force with micropipette adhesion frequency and 
thermal fluctuation assays (71). We also used DNA-based digital tension probes (50) to 
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visualize tensile forces generated by thymocytes and exerted on surface-bound pMHCs 
through TCR and CD8. Lastly, we used CD8.4 hybrid coreceptor and Lck inhibitors to test 
the contribution of Lck recruitment in these measurements. Our results showed that the 
quality, not quantity, of the pMHC bonds on thymocytes determines their selection 
outcomes. We propose a new selection model where thymocytes apply force on TCR and 
CD8 to elicit Lck-dependent cooperative trimolecular catch bonds (outside-in/inside-out) 
with negative but not positive selecting ligands, resulting in their differential pMHC 
engagement times that impact intracellular signaling and apoptosis to generate distinct 
“live or die” fates. 
5.2 Results 
5.2.1 The Formation of Lck-Dependent TCR–pMHC–CD8 Trimolecular Interaction 
Under Force Distinguishes Q4R7 from Q4H7 
A previous study from our lab has recently shown that mechanical force amplifies 
TCR’s ability to discriminate agonist and antagonist peptides by forming catch bonds with 
the former and slip bonds with the latter ligands (13). We therefore used a force-clamp 
assay (31, 102) to measure the force-dependent bond lifetime (reciprocal of off-rate) (13) 
(Figure 15A, B) as a metric of bond quality. CD4+CD8+ double-positive (DP) thymocytes 
from OTI TCR transgenic mice were used to bind two ligands (Q4H7 and Q4R7) that are 
neighboring but opposing at the selection threshold (59) to test whether these ligands show 
different characteristics under force. For both positive selecting ligand Q4H7 and negative 
selecting ligand Q4R7, the bimolecular interactions of TCR with peptides presented by H2-
Kba3A2, a mutation on the a3 domain of the MHC to abolish CD8 binding, showed slip 
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behavior where bond lifetime decreases monotonically with increasing force (brown circle, 
Figure 15C, D). The bimolecular interaction of CD8 with VSV:H2-Kb, which is a null 
peptide for OT1 TCR, was also a slip bond (black triangle, Figure 15C, D). However, when 
the peptides were presented by H2-Kb to allow for CD8 interaction, distinct trends were 
observed. Q4H7 still formed slip bonds but Q4R7 formed catch-slip bonds where lifetime 
first increased, reached a maximum (> 0.4s) around 13pN, then decreased with increasing 
force (green square, Figure 15C, D). 
Since the coreceptor CD8 is known to recruit the Src kinase Lck to the TCR 
complex during the T cell activation, we tested whether Lck inhibition had any contribution 
in the formation of catch bond under force. Recent study from Dr. Ed Palmer’s group (103) 
reported the shift of thymocyte selection threshold using a chimeric CD8.4 that has an 
extracellular portion of CD8 combined with CD4 cytoplasmic tail. The result suggests that 
higher tendency of recruiting Lck to the proximity of TCR by CD8.4 facilitate higher 
chance of triggering downstream signaling, thus providing the mechanism for antigen 
scanning and thymocyte selection. In order to test whether enhancement of Lck connected 
to the cytoplasmic tail of CD8 may facilitate any augmentation to TCR–pMHC–CD8 
complex formation under force, we re-examined OTI CD8.4 system with force-clamp 
assays. Interestingly, when force was applied to the TCR–pMHC–CD8.4, Q4H7, a positive 
selecting ligand in the OT1 CD8 system, also behaved like negative selecting ligand Q4R7 
and exhibited catch-slip bond (green square, Figure 15E, F). Despite this effect due to 
increase Lck binding propensity to CD8, the necessity of CD8.4 binding to the H2-Kb was 
essential to the catch bond, just like in the OTI CD8 system, as bimolecular TCR-pMHC 
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interaction still showed slip bond (brown circles, Figure 15E, F), indicating that TCR–
pMHC–CD8.4 interaction at the extracellular portion is critical for discrimination.  
To further test the role of Lck cooperative CD8 binding under force, we 
preincubated OT1 thymocytes with Lck inhibitor (7-Cyclopentyl-5-(4-phenoxyphenyl)-
7H-pyrrolo[2,3-d]pyrimidin-4-ylamine) and ran force-clamp assay in the presence of the 
inhibitor. Whereas the bond lifetime of positive selecting ligand Q4H7 had minimal effect 
from the Lck inhibition (green squares, Figure 15G), negative selecting ligand Q4R7 
shifted from a catch-slip bond to a slip-bond in the presence of the Lck inhibitor, suggesting 
the influence of Lck in force-enhanced CD8 cooperativity (green squares, Figure 15H). 
These findings were corroborated by results from OT1 CD8.4 thymocytes under Lck 
treatment. Q4H7, which formed a catch-slip bond in the CD8.4 system (black triangles, 
Figure 15I), exhibited a slip-bond in the presence of the Lck inhibitor, while Q4R7 retained 
its catch-slip behavior (black trianges, Figure 15J), suggesting that Lck plays a bigger role 
in aiding the formation of TCR-pMHC-CD8 interaction for weaker ligands, and to a less 
extend for stronger ligands. Overall, these data support that Lck may facilitate the 
formation of TCR–pMHC–CD8.4 trimolecular interaction as previously suggested and 
once those complexes tend to form, force-regulation may determine differential bond 
lifetimes for selection threshold. 
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Figure 15 - Distinctive Lck-dependent and force-prolonged lifetimes of OTI TCR 
and/or CD8 bonds with positive and negative selecting ligands. (A) Micrograph of the 
BFP setup in force-clamp assays. BFP uses a glass bead to present the pMHC. (B) 
Schematic showing the interacting molecules: pMHC coated on RBC or BFP bead surface 
via biotin–streptavidin (SA) coupling (left), and the TCR-CD3 complex and CD4 and CD8 
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coreceptors expressed on the DP thymocyte membrane (right). (C-J) Lifetime vs. force 
plots of TCR bonds with Q4H7 and Q4R7 peptides presented by H2-Kbα3A2 (brown 
circle), CD8 bond with VSV:H-2Kb (black triangle), and total TCR and/or CD8 bonds 
presented by H2-Kb (green square) in three different systems, i.e., CD8, CD8,4 and CD8 
with Lck inhibitor. Purple square indicate DMSO control in E and F. Filled symbols in G 
and H indicate data from Lck treatment. Open triangles indicate data from Lck treatment 
in CD8.4 system, and open square indicates DMSO control in CD8.4 system. Data are 
presented as mean ± SEM. 
5.2.2 The Stiffness of the Bond Under Force Distinguishes Q4R7 from Q4H7 
One interesting finding from the force assay data is that linear superpositions of 
two TCR–pMHC and MHC–CD8 bimolecular slip bonds cannot produce a catch bond 
regardless of how their relative contributions are adjusted. The observation of catch bonds 
therefore indicates the presence of cooperative TCR–pMHC–CD8 trimolecular 
interactions (104), which were allowed by using H2-Kb to measure total interactions. To 
directly demonstrate trimolecular bonds and to evaluate their fractions, molecular stiffness 
was analyzed (Figure 16B-D) (73, 104) as another metric of bond quality. It was reasonable 
to hypothesize that either TCR–pMHC or MHC–CD8 bimolecular complex (Figure 16E) 
should be less stiff than the TCR–pMHC–CD8 trimolecular complex (Figure 16F). The 
histograms of molecular stiffness of MHC–CD8 bimolecular bond in either normal OTI 
(Figure 16G) or OTI CD8.4 system (Figure 16H), as well as TCR–pMHC bimolecular 
bonds for Q4H7 (Figure 16I) and Q4R7 (Figure 16K), showed a single mode well-fitted 
by Gaussian distributions of the same mean (0.17 pN/nm). However, bimodal histograms 
of molecular stiffness were observed for the total bonds of negative selecting ligand Q4R7 
(Figure 16L). The bimodal histogram is statistically better fitted by a double Gaussian 
distribution (p<0.05, F-test) than the single one with the first mean equal to, and the second 
mean much stiffer (0.51 pN/nm) than the mean of the mono-modal histograms of the 
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bimolecular bonds. Interestingly, the molecular stiffness histograms of total bonds for the 
positive selecting ligand Q4H7 (Figure 16J) remain mono-modal and its double Gaussian 
fits is no better than single Gaussian fits (p>0.1, F-test). Thus, the presence and absence of 
a stiffer subpopulation for the respective negative and positive selecting ligands correlates 
with the presence and absence of trimolecular bonds, and is well-suited as a secondary 
readout of coreceptor contribution in the formation of trimolecular complex. In addition, 
while the inhibition of Lck on OT1 thymocytes had no effect on the positive selecting 
ligand Q4H7 histogram (Figure 16Q, R), it eliminated the stiffer population in the total 
bonds of negative selecting ligand Q4R7 (Figure 16S, T), suggesting that the formation of 
trimolecular interaction cannot occur in the absence of Lck activity. 
Interestingly, the molecular stiffness readout applies very well in the CD8.4 system 
where the selection threshold has shifted, making Q4H7 a negative selecting ligand. For 
instance, the histogram of molecular stiffness for Q4H7 bound to H2-Kb using CD8,4 
system yielded bimodal distribution (Figure 16N) just like that of Q4R7 (Figure 16P), 
further providing evidence for the enhancement of TCR–pMHC–CD8.4 binding from the 
enhancement of Lck recruitment. In comparison, CD8.4 system testing TCR–pMHC 
bimolecular bonds for Q4H7 (Figure 16M) and Q4R7 (Figure 16O) show only a single 
mode Gaussian distribution.  
Overall, our findings on molecular stiffness demonstrated that bimolecular bonds, 
are well-characterized by a single mode Gaussian distribution, while the presence of both 
bimolecular and trimolecular interactions, formed exclusively by negative selecting 
ligands, results in a bimodal distribution with the second peak occurring at a higher 
stiffness value. The presence of the second peak from molecular stiffness analysis 
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combines well with the force vs lifetime results and serves as a good indicator for the 
presence of trimolecular interactions. 
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Figure 16 - Molecular stiffness analysis reveals trimolecular bonds with negative but 
not positive selecting ligands. (A) Force vs. time trace of a BFP force-clamp assay 
representing a typical test cycle indicating thymocyte impingement from its contact with 
the BFP bead, retraction of the bead to release compression and pulling of the molecular 
interaction with a ramp tension, and holding at a pre-determined clamp force for lifetime 
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measurement until bond dissociation. (B) Force (left ordinate, blue) and displacement 
(right ordinate, red) vs. time traces corresponding to the ramping portion in A. (C) Force 
vs. displacement trace obtained by combining the two traces from B to eliminate time. (D) 
Illustration of how molecular stiffness is determined from direct measurement. Two line 
segments (blue dashed lines, C) were fit to data to allow for evaluation of the slopes. Their 
reciprocals equal, respectively, the compliance of the cell in compression, 1/kc, and the sum 
of compliances of the molecule and of the cell in tension, 1/km + 1/kc. (E) Mechanical 
model (two springs in parallel) for the TCR–pMHC–CD8 trimolecular complex. (F) 
Mechanical model (spring) for the TCR–pMHC and MHC–CD8 bimolecular complex. (G, 
H) Molecular stiffness histograms of CD8 and CD8.4 bonds with VSV:H2-Kb. (I-T) 
Molecular stiffness histograms in CD8, CD8.4 and CD8 with Lck treatment system of OTI 
TCR bonds with Q4H7 and Q4R7 peptides presented by H2-Kbα3A2 (I, M, Q for Q4H7 
and K, O, S for Q4R7); and total TCR and/or CD8 bonds with peptides presented by H2-
Kb (J, N, R for Q4H7 and L, P, T for Q4R7). Data (bar) were fitted globally by a single 
(black curve) or double (black curve = green curve + cyan curve) Gaussian with the same 
soft (0.17pN/nm) and stiff (0.51pN/nm) means for all panels but with different standard 
deviations and different fractions for the soft and stiff subpopulations. F-test shows the 
double Gaussian distribution fit the data significantly better than the single Gaussian 
distribution for Q4R7 (p<0.002) but not for Q4H7 (p>0.1). 
5.2.3 Thymocytes Pull More on Q4R7 via Both TCR and CD8 But Less on Q4H7 via TCR 
Only to Induce Differential Functionalities 
Our data thus far have demonstrated the crucial role of force by applying it 
externally via a BFP. We next tested the hypothesis that thymocytes exert internally-
generated force on the TCR and coreceptor to pull on pMHC on the APC surface, thereby 
eliciting catch and slip bonds to determine their fates. We tagged pMHC with a DNA-based 
digital tension probe whose DNA-hairpin unfolds at a designed tension (chosen to be 4.7 
or 13.1 pN) to de-quench a Cy5 fluorophore (Figure 17A), thereby reporting an above 
threshold force applied to the ligand (Figure 17B-D) (50, 51). As reported previously, we 
observed inefficient thymocytes spreading on the glass surface (105) which led to relatively 
low frequency of Cy5 positive signaling (<10%). Of those, we managed to find thymocytes 
that formed multifocal immunological synapse (106) which showed signaling for Q4H7 
and Q4R7. 
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The differences between fluorescence signals for peptides bound to H2-Kba3A2 
(Figure 17E) and H2-Kb (Figure 17F) report the number of cooperative TCR–pMHC–CD8 
trimolecular bonds pulled by thymocytes with >13.1pN of forces. Thus, upon ligand 
recognition by the TCR, the CD8 was induced to pull on Q4R7 (red, Figure 17F) but not 
on Q4H7 (blue, Figure 17F). In addition to comparing different thymocytes at a fixed time 
point, we also followed the same thymocytes over 10 minutes after initial surface contact 
(Figure 17G, H). The fluorescence signal decayed over time more slowly on H2-Kb bound 
to Q4R7 than Q4H7 (Figure 17H), demonstrating that thymocytes exert more sustained 
forces on negative selecting ligands compared to positive ones. Using H2-Kba3A2 to 
prevent CD8 binding greatly accelerated the decay of force signal for Q4R7 but not so 
much for Q4H7, as it was fast even in the H2-Kb condition (Figure 17G). This shows that 
CD8 binding is required for thymocytes’ more sustained pulling on negative selecting 
ligands. It also reveals that CD8 binding plays a minimum role in thymocytes’ pulling on 
positive selecting ligands. In comparison, with the increase in Lck association to corecptor 
CD8, the results from OTI CD8.4 system showed the Q4H7 bound to H2-Kb (Figure 17J) 
but not H2-Kba3A2 (Figure 17I) displayed higher Cy5 intensity comparable to that of 
Q4R7. The fluorescence signal decay also showed the similar effect where Q4H7 bound to 
H2-Kb (Figure 17K), but not H2-Kba3A2 (Figure 17L), had a more sustained signal with 
slower decay similar to that from Q4R7. In addition, whereas the inhibition of Lck had no 
effect on the Cy5 intensity of positive selecting ligand Q4H7 (Figure 17M, O), it eliminated 
the higher Cy5 intensity in the negative selecting ligand Q4R7 (Figure 17N, P). Therefore, 
Lck was found to be responsible for inducing CD8 synergizes with the TCR to enable 
thymocytes to generate sustained pulling force on negative but not positive selecting 
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ligands, as when Lck signaling or CD8 binding was prevented, the significant differences 
between force signals for Q4R7 and Q4H7 vanished. Thus, the differences between 
fluorescence signals for peptides bound to H2-Kb and H2-Kba3A2 (Figure 17F minus E, 
Figure 17J minus I, and Figure 17N minus M values for matched ligands) report the number 
of cooperative TCR–pMHC–CD8 trimolecular bonds pulled by thymocytes with >13.1pN 
of forces. Taken together with the force vs. lifetime data and molecular stiffness analysis, 
DNA force probe results provide a third orthogonal readout highlighting the contribution 
of CD8 in TCR-pMHC-CD8 trimolecular interaction in a Lck-dependent manner through 
a direct visualization of pull force exerted by TCR and/or CD8 on pMHC molecules. 
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Figure 17 - Thymocytes pull on TCR and CD8 engaged with Q4R7 but not with Q4H7. 
(A) Schematic image of pMHC-connected single hairpin DNA force probe engaging with 
TCR complex. (B-D) Representative thymocyte images on Q4R7 (B), Q4H7 (C), and VSV 
(D) tagged with a 13.1pN DNA force probe viewed in the bright-field (left column), 
fluorescence (middle column), and merged (right column) channels. (E, F for CD8; I, J for 
CD8.4; M, N for CD8 with Lck treatment) Quantitative comparison of normalized 
fluorescence intensity for indicated peptides bound to H2-Kbα3A2 (E, I, M) or H2-Kb (F, 
J, N). Normalized fluorescence intensity was calculated by dividing the mean fluorescence 
intensity from a Cy5 positive (above the VSV control) cell by the background calculated 
from single cell-sized ROI. Each positive signaling cell is presented by a circle with mean 
± s.e.m. of all positive cells. (G, H for CD8; K, L for CD8.4; O, P for CD8 with Lck 
treatment) Normalized fluorescence intensity decay in selective area of Cy5 signal of 
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thymocytes on indicated peptides bound to H2-Kbα3A2 (G, K, O) or H2-Kb (H, L, P). For 
quantitative comparison, the normalized fluorescence intensities post background 
subtraction were normalized again by the value at the initial time (t = 0 minute). Data are 
presented with mean ± SEM. normalized fluorescence intensity. Student’s t-test was used 
for statistical analysis at each time point. 
5.2.4 Lck-dependent TCR-pMHC-CD8 interaction under force distinguishes thymocyte 
selection 
The comparison between Q4H7 and Q4R7 in bond lifetime measurement, stiffness 
analysis, and DNA force probe experiments suggested that TCR-pMHC-CD8 interaction 
may have a distinct threshold for thymocyte selection.  Thus, we tested additional ligands 
that span across the selection boarder. Consistent with previous observation using Q4H7 
and Q4R7, slip bonds were observed for positive selecting ligands (Figure 18D-F) 
including endogenous ligands (60, 61) (Figure 18F). However, in the case of negative 
selecting ligands, catch bond was observed (Figure 18A-C). Moreover, we verified our 
observation in another TCR system (2C), confirming that negative selecting ligands form 
catch-slip bonds with longer bond lifetime whereas the positive selecting ligands formed 
slip bonds (Figure 19A).  
Furthermore, the stiffness analysis showed the presence of bimodal distribution for 
negative selecting ligands whereas only single distribution for positive selecting ligands 
(Figure 18E). When calculating the bond fraction, trimolecular bond fraction ft increases 
with the ligand biological activity at the expense of the bimolecular bond fraction fb (to 
satisfy fb + ft = 1) (Figure 18I), suggesting that the cooperative binding is peptide-
dependent and hence TCR-induced. These observations have been confirmed by Dr. 
Jinsung Hong (former member of our lab) using the 2C TCR (Figure 19E). Regardless of 
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the peptides, the data of TCR–pMHC bimolecular bonds fitted well by a single Gaussian. 
For the negative selecting ligands, the data of total TCR and CD8 bonds fitted by a double 
Gaussian significantly (p<0.01, F-test) better than single Gaussian, whereas for the positive 
selecting ligands, the total bond data were fitted equally well by a single or double Gaussian 
distribution, i.e., there are no statistical differences (p>0.1, F-test) in the cn2 values that 
measure the goodness-of-fit. 
In addition, to identify the dissociation characteristics of the stiff and soft fractions 
of bonds, we analyzed the lifetime distributions of total bonds with a two-state model (107). 
The model assumes that the total bonds consist of two subpopulations, one short-lived 
(fraction ω1) and the other long-lived (fraction ω2 = 1 - ω1), with respective fast and slow 
off-rate koff1 and koff2. The lifetime distributions measured under 10-15pN of forces were 
fitted by the two-state model (Figure 18J) and the state fractions ω1 and ω2 are shown in 
Figure 18K. The resemblance between Figure 18I and Figure 18K provides further support 
for the assertion that stiffer bonds are longer-lived. 
Lastly, DNA-based digital tension sensor experiments showed that the thymocytes 
pull on ligands in a selection dependent manner. Except for the noncognate VSV, both 
Catnb and OVA peptides demonstrated Cy5 signaling indicating the TCR-specificity of 
these force signals (Figure 18L-N). Importantly, the ability for a ligand to form catch bonds 
correlates with its ability to induce sustained pulling by thymocytes. This correlation was 
observed not only on the trimolecular catch bonds of the negative selecting ligands formed 
with both the TCR and CD8 (Figure 18O) but also on the bimolecular catch bond of the 
antigenic ligand OVA formed with the TCR only (Figure 18A), as sustained forces were 
also observed on OVA:H2-Kba3A2 (Figure 18Q). Only background fluorescence was 
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observed when thymocytes were placed on VSV:H2-Kb surfaces (Figure 18L, O), 
indicating that without TCR recognition, thymocytes were unable to exert appreciable 
force on CD8 alone. In addition, using lower force threshold DNA probe (4.7 pN) further 
supported our observation (Figure 19B-D). Furthermore, the de-quenching Cy5 signal was 
diminished over time when the actin filaments were disrupted by Latrunculin A or when 
myosin contraction was prevented using the ROCK inhibitor Y-27632 (Figure 19F, G), 
indicating that pMHCs were pulled by actomyosin-based forces generated by the 
thymocytes. This observation is consistent with prior studies highlighting the role of actin 
polymerization and myosin II-dependent contraction in transmitting force to TCR bound 
to pMHC (10-12, 108). Thus, upon ligand recognition by the TCR, thymocytes exert 
actin/myosin-dependent force to induce the CD8 to engage in the formation of trimolecular 




Figure 18 – Distinctive Force-dependent lifetime of OT1 TCR and/or CD8 Bonds with 
Positive and Negative Selecting Ligands. (A-E) Lifetime vs. force plots of TCR bonds 
with OVA, Q4, T4, Q7, and G4 peptides presented by H2-Kbα3A2 (brown circle), CD8 
bond with VSV:H-2Kb (black triangle), and total TCR and/or CD8 bonds presented by H2-
Kb (green square). (F) Lifetime vs. force plots of TCR bonds with endogenous peptides 
Catnb and Capp1 (blue) and CD8 bond with VSV:H-2Kb (black triangle). (G,H) Molecular 
stiffness histograms of OTI TCR bonds with OVA, Q4, T4, Q7, G4, and VSV peptides 
presented by H2-Kbα3A2 (H); and total TCR and/or CD8 bonds with peptides presented 
by H2-Kb (G). Data (bar) were fitted globally by a single or double Gaussian with the same 
soft (0.17pN/nm) and stiff (0.51pN/nm) means for all panels but with different standard 
deviations and different fractions for the soft and stiff subpopulations. (I) Fraction of 
bimolecular and trimolecular interaction formed by OT1 thymocyte with positive selecting 
(blue) and negative selecting (red) ligands obtained from Gaussian fitting of spring 
constant analysis. (J) Normalized lifetime distribution of total 2D TCR and/or CD8 bonds 
with H2-Kb bound to the indicated peptides measured at 10-15 pN by force-clamp assay. 
(K) Fraction of short-lived (gray bar) and long-lived (white bar) bonds from fitting with 
two-state model (107). (L-N) Representative images of VSV (L), Catnb (M), and OVA 
(N) tagged with a 13.1pN DNA force probe viewed in the bright-field (left column), 
fluorescence (middle column), and merged (right column) channels. (O) Quantitative 
comparison of normalized fluorescence intensity for VSV, Catnb and OVA. (P) 
Quantitative comparison of normalized fluorescence intensity (points, left ordinate) and 
fraction of positive cells (bars, right ordinate) for anti-CD3 and OVA in DP thymocytes 
and SP splenocytes. (Q) Normalized fluorescence intensity decay in selective area of Cy5 




Figure 19 - Distinctive force-dependent lifetime of 2C TCR and/or CD8 bonds with 
positive and negative selecting ligands and thymocyte pulling reported by 4.7 pN DNA 
force probe. (A) Lifetime vs. force plots of TCR bonds with SIYR, dEV8, and EVSV 
peptides presented by H2-Kbα3A2 (brown circle), CD8 bond with VSV:H-2Kb (black 
triangle), and total TCR and/or CD8 bonds presented by H2-Kb (green square). Lifetime 
vs. force plots of total TCR and/or CD8 bonds with dEV8:H-2Kbm3 (red square) and 
p2Ca:H-2K (blue diamond). (Data obtained by Dr. Jinsung Hong) (B) Representative 
thymocyte images on indicated ligands tagged with a 4.7pN DNA force probe viewed in 
the bright-field (left column), fluorescence (middle column), and merged (right column) 
channels. (C) Quantitative comparison of normalized fluorescence intensity (points, left 
ordinate) and fraction of positive cells (bars, right ordinate) for indicated peptides bound 
to H2-Kb. Normalized fluorescence intensity was calculated by dividing the mean 
fluorescence intensity from a Cy5 positive cell by the background. Data are presented as 
mean ± SEM of all positive cells (each cell is represented by a circle with N≥9 from at 
least 292 total cells). Asterisks (**) denotes p<0.01 from Student’s t-test. (D) Normalized 
fluorescence intensity decay in selective area of Cy5 signal of thymocytes on indicated 
peptides bound to H2-Kb. For quantitative comparison, the normalized Cy5 intensities were 
normalized again by the value at the initial time (0min). Data are presented with mean ± 
SEM. of normalized fluorescence intensity. Asterisks (*) denotes p<0.05 from Student’s t-
test. (E) Molecular stiffness histograms of 2C TCR bonds with SIYR, dEV8, and EVSV 
bound to H-2Kbα3A2 (I-III), total TCR and/or CD8 bonds with these peptides (IV-VI) and 
p2Ca bound to H-2Kb (VII) or dEV8 bound to H-2Kbm3 (VIII). Data (bar) were fitted 
globally by a single or double Gaussian per panel with the same soft (0.20pN/nm) and stiff 
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(0.55pN/nm) mean(s) for all panels but different panels could have different standard 
deviations and different fractions for the soft and stiff subpopulations. (Data analyzed by 
Dr. Jinsung Hong) (F) Representative thymocyte images on OVA:H2-Kb tagged with a 
13.1pN DNA force probe treated with DMSO control (I), an actin polymerization inhibitor 
latruculin A (II), and a ROCK inhibitor Y-27632 (III). Thymocytes before (top row) and 
10min after (bottom row) the drug treatment were viewed in the bright-field (left column), 
fluorescence (middle column), and merged (right column) channels. (G) Normalized 
fluorescence intensity decay in selective area of the Cy5 signal (normalized again to the 
value at the initial time point) over 20min. Data are presented with mean ± SEM of 
normalized fluorescence intensity (N≥11 ROI from more than 6 thymoyctes pooled from 
at least two independent experiments). Statistical analysis (one-way ANOVA) is 
performed as denoted (* = p<0.05; ** = p<0.01; *** = p<0.001). 
5.2.5 Disruption of Lck association with CD8 abolishes synergistic TCR-pMHC-CD8 
trimolecular interaction 
Since we have found earlier that increasing Lck association with coreceptor CD8 
favors the formation of TCR-pMHC-CD8 interaction and inhibition of Lck activity 
abolished trimolecular interaction for ligands near the selection threshold, we went further 
to test the robustness of our findings by abolishing the interaction between Lck and CD8. 
Using hybridoma cells expressing OT1 TCR and CD8 with a mutation on the intracellular 
CxCP motif that abolishes the interaction between CD8 and Lck (44), we measured force-
dependent lifetime of these cells and compared that with its non-mutated counterpart. As 
expected, we found that CxCP mutation abolished catch-slip behaviour of Q4R7, a 
negative selecting ligand, in comparison to WT cells without the mutation. With the 
mutation, the magnitude of bond lifetime under force of Q4R7 presented on H2-Kb MHC 
was comparable to that measured between WT cells and Q4R7 presented on H2-Kb a3A2 
condition, where CD8 interaction with MHC was not possible (Figure 20A). This result 
suggests that despite having an intact extracellular portion of CD8 for binding to MHC, 
trimolecular interaction was not formed in the absence of Lck association with CD8. When 
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OVA peptide was presented by H2-Kb MHC, the force vs. lifetime curves exhibited similar 
catch-slip bond for both WT OT1 hybridoma and the CxCP mutatant (Figure 20). This 
result is consistent with the force-dependent lifetime measurement carried out using OT1 
thymocyte against OVA pMHC. such that preventing CD8-MHC interaction using H2-Kb 
a3A2 does not result in the abolishment of catch-slip behaviour, indicating that for strong 
peptides, such as OVA, trimolecular interaction involving CD8 plays a minimal role in 
regulating force-dependent lifetime. The high potency of the OVA peptide is probably 
strong enough to surpass the selection threshold without the help of CD8 coreceptor, which 
plays a more critical role in discriminating ligands near the threshold. 
 
Figure 20 – Abolishing Lck-CD8 interaction with CxCP mutation prevents 
trimolecular interaction and affects catch-slip behavior of threshold ligand. (A) 
Lifetime vs. force plot of OT1 hybridoma WT (blue) and CxCP mutant (red) interacting 
with Q4R7 presented by H2-Kb MHC, and WT interacting with Q4R7 presented by H2-Kb 
a3A2 (black). (B) Lifetime vs. force plot of OT1 hybridoma WT (blue) and CxCP mutant 
(red) interacting with OVA presented by H2-Kb MHC. Data are presented as mean ± SEM. 
5.2.6 Reduction in the number of Lck substrates lowers synergistic TCR-pMHC-CD8 
trimolecular interaction 
In T cell signaling, Lck phosphorylates ITAMs found on the cytoplasmic tails of 
CD3. Since our findings so far strongly suggested a dependency of TCR-pMHC-CD8 
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trimolecular interaction on the activity of Lck, we went a step further to test the impact of 
reducing the number of Lck substrates per TCR. We utilized thymocytes from OT1 mice 
with 6F mutation where six out of ten ITAMs on the TCR complex were mutated to abolish 
their signaling capacity (109, 110). As a result, we observed a leftward shift of bond 
lifetime against Q4 and Q4R7, two negative selecting ligands, in comparison to regular 
OT1 thymocytes (Figure 21A,B). Catch bond was still observed for these two ligands, 
despite the shift in force vs lifetime profile, indicating that there was a partial suppression 
on the formation of the synergistic TCR-pMHC-CD8 trimolecular interaction due to the 
decrease in the number of signaling ITAMs per TCR complex. 
 
Figure 21 - 6F mutation on CD3 ITAMs reduces the formation of trimolecular 
interaction. (A, B) Lifetime vs. force plots of OT1 6F TCR and/or CD8 bonds with Q4R7 
and Q4 peptides presented by H2-Kb (black square). Data are presented as mean ± SEM.  
5.3 Discussion 
Our bond lifetime measurements have demonstrated that thymocyte forms catch-
slip bond with negative selecting ligands and slip-bond with positive selecting ligands, and 
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the formation of catch bond is due to the contribution of coreceptor CD8 in forming 
trimolecular interaction with TCR and pMHC under force, as evidenced by our molecular 
stiffness analysis. In addition, we visualized force exerted by thymocyte through TCR 
and/or CD8 on pMHC using DNA force probes, further highlighting the relevance of force 
in thymocyte selection. We then investigated factors affecting the formation of TCR-
pMHC-CD8 trimolecular interaction and found that it requires Lck association to co-
receptor CD8, Lck activity, and the availability of Lck substractes, ITAMs on CD3s, for 
ligands near the selection threshold, but not potent ligands, such as OVA in the OT1 
system.  
The role of force in TCR-pMHC interaction has drawn increasing attention in 
recent years, mostly from evidence obtained from studies of mature T cells (13, 51, 99), in 
the context of thymocyte, however, the contribution of force has not been thoroughly 
investigated. Thymocyte selection, a critical step in thymocyte development that is 
primarily mediated by TCR-pMHC interaction, is likely a target subjected to the influence 
of mechanical forces. As expected, we found that thymocytes form catch bonds with 
negative selecting ligands exclusively but not the positive selecting one, which could be a 
novel criterion for ligand discrimination that is only possible under force. CD8 contribution 
in the formation of TCR-pMHC-CD8 trimolecular interaction was found to be responsible 
behind the catch bond, as positive selecting ligands displayed very similar force-dependent 
lifetime profile regardless of whether CD8-MHC interaction is prevented by mutation on 
MHC. In contrast, negative selecting ligands, with the exception of OVA, did not form 
catch bond in the absence of CD8-MHC binding. To demonstrate that thymocytes are 
capable of exerting forces, we utilized DNA force probes to fluorescently report pulling 
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forces exerted by thymocytes through TCR and CD8 on pMHC, and we found that 
thymocytes are capable of generating such pulling force, and these forces are dependent on 
actin and myosin, consistent with prior findings on mature T cells (12, 108). 
T cell triggering is commonly thought of as primarily outside-in, with input from 
pMHC sensed by TCR and CD8 dictating T cell responses. Interestingly, our findings 
revealed an inside-out component of T cell triggering. Lck association with coreceptor CD8 
and Lck catalytic activities are both influencing factors impacting the formation of CD8-
MHC interaction as part of the trimolecular complex. Despite having no change to the 
extracellular portion of TCR and CD8, CD8.4 thymocytes recognize peptides different 
from CD8 thymocytes, and the difference is manifested by the shift of selection threshold 
(111) and formation of catch-slip bond by Q4H7, a previously positive selecting ligand. 
Modifications on the intracellular portion of CD8 is thought to be downstream of TCR-
pMHC recognition in the outside-in signaling pathway, and is not expected to alter peptide 
recognition if TCR triggering is exclusively outside-in. Therefore, the change in peptide 
recognition by CD8.4 thymocytes strongly suggests that rather than a unidirectional 
outside-in pathway, TCR triggering has an inside-out component forming a loop. Based on 
existing data from our experiments and from the field, we propose the following model of 
TCR outside-in/inside-out loop. The outside-in component consists of two dimeric 
interactions, one between TCR and pMHC, and the other between CD8 and MHC. The 
inside-out loop consists of CD8 in association with Lck, which in turn associates with CD3 
tails of the TCR complex. Upon receiving the readout from the outside-in component, the 
cytoplasmic tails of CD3 dissociates from the plasma membrane (27) and becomes 
available for binding to Lck, resulting in phosphorylation of ITAMs by Lck. As Lck 
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molecules are recruited to the TCR complex through association with CD8 (112), the 
interaction between between Lck and CD3 helps to keep CD8 in the proximity of TCR and 
increases the chance of CD8-MHC interaction and promotes rebinding of CD8 to existing 
TCR-pMHC interaction, thus favoring the formation of trimolecular interaction (Figure 
22). Essentially, the inside-out component provides an additional level of check through 
favoring the formation of trimolecular interaction with certain peptides, resulting in 
prolonged lifetime of interaction of TCR with these peptides surpassing a certain threshold, 
leading to differential cellular responses from the T cell.  
It remains unclear exactly how does TCRs on thymocyte differentiate pMHCs prior 
to the onset of CD8-MHC binding, since force-dependent lifetime shows comparable 
profile and magnitude of TCR-pMHC interaction for ligands across the selection threshold, 
and we speculate that small differences in the outside-in readout get amplified by the 
inside-out component of the TCR signaling loop, resulting in a larger difference for T cell 
decision making. It is worth noting that OVA is able to form catch-slip bond without CD8 
participation, and we reason that this exception is due to the high potency of OVA 
compared to the other peptides tested such that TCR recognition OVA-loaded MHC is able 
to make signaling decisions without receiving help from CD8 to amplify the outcome from 
the outside-in portion of the signaling loop. Further effort to investigate this initial 
difference in TCR-pMHC recognition on thymocyte is warranted to fully understand the 
events revolving around TCR triggering.  
In summary, we have demonstrated the contribution of force in the formation of 
TCR-pMHC-CD8 trimolecular interaction, resulting in prolonging of the lifetime of 
interaction with negative selecting peptides. This novel force-dependent readout is capable 
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of differentiating negative selecting peptides from the positive selecting one, thus acting as 
a unique criterion for antigen discrimination in the context of thymocyte selection. 
Furthermore, by investigating the various factors affecting the formation of this 
trimolecular interaction, we propose a new model of TCR triggering with the addition of 
an inside-out signaling component creating a signaling loop with the well-known outside-
in portion mediated by TCR recognition of pMHC.  
 
Figure 22 - TCR outside-in/inside-out signaling loop consists of the extracellular 
outside-in portion involving two dimeric interactions (TCR-pMHC and MHC-CD8), 
and the inside-out portion containing Lck bridging together CD3 and CD8. 
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CHAPTER 6. CONCLUSIONS AND FUTURE DIRECTIONS 
6.1 Conclusion 
I presented in this thesis a two-part study revolving around the role of force in TCR 
triggering. In the first part, I focused on characterizing TCR-CD3 extracellular interaction 
and probing the significance of this force-dependent interaction in TCR triggering. In the 
second part, I investigated the formation of TCR-pMHC-CD8 trimolecular interaction 
under force in the context of thymocyte selection to relate our findings from the kinetics 
aspect to functional outcomes affecting cell fate. 
In the study of TCR-CD3 interaction, I presented the first 2D kinetics measurement 
of TCR-CD3 and CD3-CD3 extracelluar interactions. I found that these interactions exhibit 
catch-slip behavior, with the optimal lifetime of TCR-CD3 interaction occurring at the 
same force range that gives rise to the longest TCR lifetime with agonist pMHC, suggesting 
that TCR-CD3 play a potential role of relaying force signal from pMHC recognition end 
to the intracellular signaling end. Furthermore, I identified that mutations that affect the 
extracellular TCR-CD3 interaction also impact TCR antigen recognition, thus highlighting 
the importance of TCR-CD3 extracellular interaction as a critical player in TCR triggering. 
In the study of the role of force in the formation of TCR-pMHC-CD8 trimolecular 
interaction, we identified a novel criterion for thymocytes to discriminate negative 
selecting ligands from positive selecting ones. Thymocytes were found to form catch-slip 
bond with negative selecting ligands but not positive selecting ones, and this catch-slip 
behavior is the result of CD8 contribution to TCR-pMHC interactions. We further 
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investigated and identified Lck association with Lck and Lck catalytic activities as two 
important factor determining the formation of CD8-MHC interaction, thus allowing us to 
formulate a new model of TCR triggering involving not only a unidirectional outside-in 
portion but also an inside-out component mediated by Lck association with both CD8 and 
CD3. The inside-out portion selectively favors the participation of CD8 in TCR-pMHC 
interactions for certain peptides by reacting to the outcome from the outside-in from initial 
TCR-pMHC interaction.  
6.2 Future directions 
Findings presented in this thesis contribute to the field in 1) providing direct evidence 
to identify specific interaction between the extracelluar domains of TCR and CD3, an area 
that lacked direct measurements previously, and 2) relate TCR-pMHC-CD8 trimolecular 
interaction to the functional outcome of T cells in the context of thymocyte selection and 
highlight the role of force in mediating such interaction. These new findings add to and 
refine existing models of TCR triggering, but our understanding on the whole process of 
TCR triggering is far from complete. With these new information, more questions are 
generated.  
Conformational change occurring at the transmembrane portion of CD3 has been 
reported previous (9), but what sequence of events lead to this conformational change is 
still unclear. It is likely that changes in the transmembrane region occurs due to force 
exertion on the extracellular site originated from TCR-pMHC interaction, but more direct 
evidence connecting these two events needs to be established. Going beyond the 
transmembrane region, dissociation of CD3 cytoplasmic tails from the plasma membrane 
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has long been suggested to be a direct consequence of TCR ligation (27). What is the role 
of force in CD3 tail dissociation? If the extracellular interaction between TCR-CD3 serves 
as a relay of mechanical forces across the membrane, it is possible that applying a sustained 
force on TCR or CD3 can lead to the dissociation of CD3 tails from the membrane. Single-
molecule imaging, coupled with a direct method of monitoring force (i.e. through DNA 
force probes) or applying forces on specific surface molecules (i.e. through BFP assay) 
could unravel the direct relationship between force and CD3 tail dissociation. It would be 
beneficial to experiment with various TCR mutations aimed at affecting TCR-CD3 
mutation to investigate the consequences of scenarios where the relay of force signals get 
disrupted. 
Pertaining to thymocyte selection, it is still unclear how does TCR differentiate 
different peptides prior to CD8 engagement to MHC. Docking geometries and interaction 
kinetics are both possible candidates, although our findings showed comparable lifetime of 
TCR-pMHC interaction for ligands near the threshold either with or without force. TCR-
pMHC interaction on thymocyte is also different from that on naïve T cells, as the latter 
forms catch-slip bond with agonist pMHCs without CD8 participation (13). What are the 
causes of these differences on the level of pMHC recognition? To further advance our 
understanding on TCR triggering and stay relevant to physiological conditions, we also 
need to probe into the role of self pMHCs.  Since T cell naturally needs to discern its 
antigen from a large number of self-peptides, the contribution of other MHC molecules to 
TCR triggering warrants more attention. Even though MHCs loaded with self-peptides are 
not expected to interact with TCR, they can still form interaction with coreceptors. Taking 
into consideration the inside-out arm of TCR signaling, association of Lck to CD3 keeps 
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CD8 close to the TCR complex, which gives rise to the possibility for CD8 to bind to other 
neighboring MHCs, many of them are those carrying self-peptides under physiological 
conditions. In addition, a TCR complex is not restricted to one CD8 coreceptor, making it 
very likely that CD8 binding to MHC can bridge multiple MHC molecules together and 
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